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Whether you can observe a thing or not depends on the theory which you use. 
 It is the theory which decides what can be observed. 
Albert Einstein,  
objecting to the placing of observables 
 at the heart of the new quantum mechanics, 
 during Heisenberg's 1926 lecture in Berlin.     iii 
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1  Thesis motivation and objectives 
Protein-ligand  docking  is  a  widely  used  tool  in  basic  and  applied  pharmaceutical 
research.  The  appearance  of  the  first  three-dimensional  structures  of  proteins 
immediately sparked the interest in developing methodologies that theoretically predict 
the binding  mode and the  interaction energy of putative  ligands of them. Since the 
beginning of the 80s (Kuntz, et al., 1982), docking remains a field of intense research 
(Kitchen, et al., 2004; Cavasotto and Orry, 2007). This has already crystallized in a 
significant number of success stories in both Virtual Screening (VS) applications, aimed 
at identifying new binders to a target (Kitchen, et al., 2004; Cavasotto and Singh, 2008), 
and  in  ligand  optimization  efforts,  the  most  popular  among  them  being  the 
commercialized drug imatinib (Gleevec) (Capdeville, et al., 2002). Yet docking is not 
perfect and there is still room and need for improvement. 
Docking  comprises  both  generating  good  protein-ligand  geometries  and  properly 
estimating of the interaction energy of the binding partners. For the first task, reported 
success  rates  reach  80%  of  the  cases  (Warren,  et  al.,  2006).  The  second,  more 
challenging, translates in variable success that range from 10 to 70% in discriminating 
native  complex  structures  from  decoys  and  almost  inability  to  correctly  rank-order 
series of ligands according to their binding potency (Warren, et al., 2006). These figures 
have led to the commonly held view that in docking, the geometry problem has been 
resolved  to  a  sufficient  extent  and  the  scoring  problem  remains  the  open  question. 
However, Velec et al. have recently shown that both problems are so intimately related, 
that good geometries are indeed a pre-requisite for improving scoring functions (Velec, 
et  al.,  2005).  Along  these  lines,  the  authors  argued  that  the  commonly  accepted 
geometric accuracy  limit of 2  Å root-mean-squared-deviation (RMSD) to the native 
crystal structure is far too large for subsequently performing a reliable scoring, and thus 
focus must be still kept in generating better geometries. An analogous observation has 
been made in an experimental study of a series of matrix metalloproteinases inhibitors, 
where  “correct”  docking  solutions  were  not  “good  enough”  for  explaining 
experimentally observed differences in affinity (Bertini, et al., 2007). 
The need for improvement in docking (Leach, et al., 2006a) is augmented from recent 
developments in two fields. First, advances in molecular and systems biology have lead Thesis motivation and objectives    2 
     
to the identification of more and more biochemical pathways and signaling routes that 
explain the physiology of the cell and the organisms. Specifically, this has crystallized 
in  the  emerging  therapeutic  class  of  protein-protein  interfaces  (PPI).  The  structural 
characterization of these PPI, key for rational exploitation, represents a challenge for 
both,  experimental  (NMR  and  X-ray  crystallography)  and  theoretical  techniques 
(Pagliaro,  et  al.,  2004;  Russ  and  Lampel,  2005;  Gonzalez-Ruiz  and  Gohlke,  2006; 
Imming, et al., 2006;  Weigelt, et al., 2008). With respect  to the  latter, it has  been 
argued, that success of current docking approaches has been largely facilitated by the 
steric constraints imposed by well-defined deep cavities that exist in enzymatic targets 
(Ferrara,  et  al.,  2004),  which  contrasts  sharply  with  the  observation  that  PPI  are 
typically flat and devoid of deep binding sites for small molecules (Pettit and Bowie, 
1999) as exemplified in Figure 1.1.  
 
Figure  1.1  Comparison  of  the  “deep”  and  well-defined  binding  pocket of  a typical 
enzymatic target (A) (Dihidrofolate reductase complexed with methotrexate; PDB 
ID:  1df7)  to  the  “rather  flat”  interacting  surface  involved  in  a  protein-protein 
interaction (B) (X-linked inhibitor of apoptosis protein complexed with a Smac 
mimetic; PDB ID: 2jk7). 
The  second  field  longing  for  substantial  improvements  in  protein-ligand  docking  is 
fragment-based VS. Fragment-based techniques are a rather young approach, but which 
has already gained deserved attention from the medicinal chemistry community (Hajduk 
and Greer, 2007; Congreve, et al., 2008). However, there is an open debate whether 
current  docking  tools  are  appropriate  for  dealing  with  fragments,  due  to  the 
comparatively larger binding site regions given the size of the ligand and the supposed Thesis motivation and objectives    3 
     
“over-training” of current tools  for more “drug-like”  ligands (Hubbard, et al., 2007; 
Marcou and Rognan, 2007; Chen and Shoichet, 2009). 
Together with the continuing effort to improve docking by better treatment of target 
flexibility and prediction of water molecules mediating in the interaction, there is an 
attempt at improving the physical description of the interaction by considering scoring 
functions  with  more  sophisticated  entropic  and  electrostatic  treatments.  Meanwhile, 
while progress in this “general docking” approach happens slowly, practical alternatives 
solutions for specific problems start to emerge. Among such alternatives, probably the 
most  interesting  are  “tailored  scoring  functions”.  Here,  the  idea  is  to  harness  and 
integrate readily available  information  for a given target either  from a collection of 
known binders (Fradera and Mestres, 2004; Jansen and Martin, 2004; Radestock, et al., 
2005), or from directly measured experimental data for the complex under study (van 
Dijk, et al., 2005a) to guide/restrain docking. This present work falls  in the  second 
category. 
The  synergy  between  directly  measured  experimental  data  and  theoretical  docking 
methods made possible to study biological systems that were considered intractable or 
very challenging before. Remarkably, they have given a boost to the challenging field of 
protein-protein docking (van Dijk, et al., 2005a). Not surprisingly, now efforts are also 
being put in the protein-ligand docking field, specially in connection with NMR data 
(Carlomagno,  2005;  Powers,  2007).  There  are many  NMR  observables  that  provide 
information about the structure of a biomolecular system. Chemical shifts (CS) are the 
most  fundamental  ones,  and  key  for  assigning  NMR  spectra,  but  not  considered 
optimum for deriving structure (Szilagyi, 1995). On the one hand, the CS of a nucleus 
in a magnetic field reflects the chemical environment surrounding the nucleus. On the 
other hand, the CS results from a combination of numerous and complex effects. This 
means  that  different  chemical  environments  can  lead  to  similar  CS  which  makes 
structure elucidation based on CS alone a difficult or unaccomplishable task. But the 
situation has changed recently. More data about CS in proteins have accumulated in 
public data bases (Ulrich, et al., 2008) thus improving our understanding and modeling 
accuracy.  Together  with  the  increasing  availability  of  computer  power,  CS  find 
increasingly more applicability in structural characterization of biomolecules (Wishart Thesis motivation and objectives    4 
     
and  Case, 2001; Hunter, et al., 2005). I will  focus on their use  in  for the  study of 
protein-ligand complexes. 
If the CS of a nucleus is an expression of its chemical environment, a change in that 
environment produced by the binding of a ligand to a protein results, consequently, in a 
chemical shift perturbation (CSP). CSP of isolated atoms in a protein do not provide 
much  structural  information,  but  taken  all  CSP  measured  on  the  protein  side  upon 
ligand binding it is possible to precisely define binding site regions. Such simple idea is 
the principle of SAR  by NMR, a successful  fragment-based  ligand design approach 
established  in  the  last  decade  (Shuker,  et  al.,  1996).  The  qualitative  approach 
(perturbation observed or not), nicely circumvents the aforementioned difficulties to 
interpret and model CSP. But at the same time, it does not provide information about 
the relative orientation of the ligand to the protein, a task which can be deferred to a 
standard  docking  program.  The  logical  step  forward  for  better  exploiting  structural 
information  contained  in  CSP  was  to  consider  them  semi-quantitatively  or  fully 
quantitatively. Among the first approaches, which consider the absolute magnitude, but 
not its sign (i.e. whether the CSP reflects an upfield or a downfield) are the one by 
Schieborr et al. (Schieborr, et al., 2005) and the one by Stark and Powers (Stark and 
Powers, 2008). I will discuss, that such approaches still fail to directly orient the ligand 
in the binding site. They keep the ligand in the binding site, but if this is large or flat 
enough or the ligand has internal symmetries, the way CSP information is incorporated 
does not contribute to properly placing it. The fully quantitative approach, by its side, 
can exploit the ring current effect as a unique feature to properly orient the ligand. Ring 
current effects leave a pattern of down- and upfields in their vicinity, depending on 
relative  ring  orientation  and  distance.  This  has  been  already  acknowledge  and 
prospectively explored by McCoy and Wyss (McCoy and Wyss, 2000) and later by 
Cioffi  et al. (Cioffi, et al., 2008) In  both cases CSP were,  however, used  for post-
filtering or optimizing docking generated solutions, with the drawback that the docking 
algorithm itself is, in some cases, unable to generate a good solution at all. As stated 
above, this is a likely situation for PPI and in fragment screening attempts. My aim has, 
therefore been to incorporating CSP information directly into a docking simulation, by 
means of a  new  hybrid  scoring  function (QCSPScore) that actively drives solutions 
towards native-like poses. Thesis motivation and objectives    5 
     
This leads to the following specific goals: 
  Evaluate  different  models  for  the  prediction  of  CSP  upon  protein-ligand 
complex formation. 
  Develop an objective function to measure the agreement between observed and 
back-calculated CSP, taking into account experimental and theoretical accuracy 
limits and efficiency considerations. 
  Combine this objective function with DrugScore, resulting in a hybrid scoring 
scheme directly applicable to standard protein-ligand docking with AutoDock. 
Establish a weighting factor for both contributions in the hybrid scoring scheme. 
  Extend AutoDock by implementing QCSPScore.  
  Test  and  validate  the  QCSP-driven  approach,  comparing  results  and 
performance to standard docking and similar approaches recently published. 
 Structure-based ligand design    6 
     
2  Structure-based ligand design 
The  discussion  about  aiding  ligand  design  with  information  from  structural  biology 
began more than 40 years ago as the first three-dimensional (3D) structures of globins, 
enzymes and polypeptides were published (Beddell, et al., 1976). However, it took still 
20 more years until the first success stories following the new paradigm of “structure-
based  ligand  design”  (SBLD)  were  reported  (Erickson,  et  al.,  1990;  Roberts,  et  al., 
1990). SBLD builds on the observation that small molecules (from now on, the ligands) 
can modulate the activity of bio-macromolecules (from now on the target, normally a 
protein) through binding to specific regions of the latter. Nowadays potent binders are 
rationally designed by optimizing structural and chemical complementarity of the ligand 
to  the  target.  Selective  binders,  for  those  cases  where  several  targets  have  similar 
binding sites, can be also designed if the structural nuances of the involved structures 
are  spotted  and  exploited  alternatively  to  prevent  and/or  enhance  the  interactions, 
respectively (Beddell, 1992; Perutz, 1992). 
The value of detailed information about protein structures is widely recognized not only 
in SBLD applications, but also in more basic biological research areas. For example, in 
the study of the proteome, a newly discovered protein can be attributed a function if a 
structurally similar one is already known, following the paradigm “structure explains 
function”.  The  success  of  such  approach  has  fuelled  ambition  to obtain  more  high-
resolution  structures  in  a  faster  way.  Policies  have  been  adopted  worldwide  and  a 
number  of  consortia  have  been  established  to  promote  research  in  improving  the 
throughput  (and  eventually  reducing  the  high  costs)  of  the  traditional  experimental 
methods for solving protein structures, i.e., X-ray crystallography and NMR (Stevens, et 
al., 2001). The outcome of such initiatives has not only resulted in an acceleration of the 
number of structures deposited in public databases in the last years (Figure 2.1), but also 
more  interestingly  in  the  development  of  a  substantial  number  of  experimental  and 
computational methods and variations available for producing structural information in 
a  cost-effective  way  (Blundell,  et  al.,  2002).  SBLD  benefits  directly  from  these 
developments  in  structural  genomics,  because  even  if  the  particular  protein-ligand 
complex structure of interest is not available, another structure of the target (free or 
bound to a different ligand) can be used for predicting the binding of a ligand of interest 
(Weigelt, et al., 2008). Structure-based ligand design    7 
     
 
Figure  2.1  Number  of  biomolecular  structures  released  from  the  protein  databank 
(PDB) per year. Source: http://www.rcsb.org/ 
SBLD is nowadays an integral component of ligand design efforts in general. A recent 
review  by Scapin  illustrates this  fact by recounting that 25-30% of the articles  in  a 
typical issue of the Journal of Medicinal Chemistry report a structure-based approach to 
inhibitor discovery and/or development (Scapin, 2006). But perhaps more compelling is 
the fact the increasing number of marketed drugs that have originated from SBLD, like 
for  example,  aliskiren  (Rasilez)  (Jensen,  et  al.,  2008),  oseltamivir  (Tamiflu)  (von 
Itzstein, 2007) and imatinib (Gleevec) (Capdeville, et al., 2002). More examples can be 
found in ref. (Congreve, et al., 2005). One can find SBLD in all stages of the drug 
design process (Figure 2.2), and research groups try to incorporate this valuable piece of 
information as soon as possible to every project when feasible. This provides a major 
strategic change, as the technique was almost exclusively used for ligand optimization. 
In  ligand  optimization,  one  tries  to  leverage  the  information  provided  by  a  known 
protein-ligand  complex.  By  studying  such  structure,  one  tries  to  find  unexploited 
binding features. For example, should there be a lipophilic sub-pocket or a potential 
hydrogen-bond donor or acceptor group in the binding site not yet exploited by the 
known ligand this would be a clear opportunity to consider for the next generation of Structure-based ligand design    8 
     
molecules to be synthesized. This simple but powerful idea has opened an avenue to the 
development of so called “structure-based compound library design” methodologies for 
a specific target. Focused libraries substantially reduce the number of compounds that 
need to be experimentally tested in search of potent and selective binders, thus saving 
resources (Orry, et al., 2006). 
Another application of SBLD has been to understand drug resistances as a consequence 
of mutations (Wong and Witte, 2004). It is possible to obtain protein-ligand complexes 
of an inhibitor with wild-type proteins, for which the inhibitor was active, and mutated 
ones. The comparison of the binding modes can reveal what are the specific protein-
ligand  interactions responsible  for the  loss of  binding affinity.  A  new generation of 
binders  should  be designed  by targeting conserved  interactions only, which are  less 
likely to mutate. 
Finally,  progress  in  high-throughput  NMR  and  X-ray  crystallography,  along  with 
increasingly  available computer power and  new algorithmic developments promoted 
SBLD to the front of the ligand design pipeline: hit finding, which applies to those cases 
where no known binders exist or totally new compound classes are sought. Soaking 
protein crystals in cocktails of chemical fragments (Hartshorn, et al., 2005), multiple 
NMR methodologies for screening (Coles, et al., 2003), and computer approaches such 
as de novo design approaches (Schneider and Fechner, 2005) and structure-based virtual 
screening techniques (Shoichet, 2004) are all recent and sophisticated developments that 
illustrate the willingness to harnessing structural information for aiding in the design of 
new ligands. Including structural information is certainly rewarding: in a recent review 
on fragment-based ligand design, Hajduk and Greer reported that “the ability to produce 
potent inhibitors (IC50 < 100 nM) after initiating lead optimization on fragment leads 
nearly  triples  with  the  aid  of  structure-based  design,  increasing  from  33%  to  93%” 
(Hajduk and Greer, 2007). Structure-based ligand design    9 
     
 
Figure  2.2  Schematic  representation  of  the  ligand  design  process.  Structural 
information of the target has been traditionally used at the final lead optimization 
phase; nowadays, thanks to developments  in X-ray crystallography, NMR, and 
high-throughput computational docking, structural information of protein-ligand 
complexes plays a role as early as in hit finding. Bringing rational design to the 
front of the pipeline has translated in increased success rates in obtaining potent 
and selective ligands. 
Although knowing the free structure of the target is advantageous, the full power of 
SBLD comes from the study of complex structures. This is particularly true for those 
cases where, for example, the binding site is only revealed by a conformational change 
of the protein to accommodate the bound  ligand (Arkin, et al., 2003). Binding of  a 
ligand to its target protein results from a very delicate balance between attractive and 
repulsive forces, and the bound conformation is not straightforwardly inferable by just 
observing  both  unbound  structures  (Gohlke  and  Klebe,  2002).  In  spite  of  that,  the 
amount of publicly available data concerning “free” structures outweighs by large that 
of  complexes.  In  addition,  if  one  analyzes  the  available  complex  structures,  an 
immediate  realization  is  that  many  targets  are  “overrepresented”.  The  “Binding 
MOAD” data base (Hu, et al., 2005), a curated subset of the PDB focused on protein-
ligand  complexes,  contains  a  total  of  ~10000  protein-ligand  complexes  relating  to 
~1800  non-redundant  targets  (http://www.bindingmoad.org/).  This  underlines  once Structure-based ligand design    10 
     
more, first, how difficult it is to obtain protein-ligand complex structures and, second, 
how target-dependently current X-ray and NMR methodologies perform. 
Particularly  challenging  for  current  techniques  are  proteins  involved  in  molecular 
signaling through direct interaction with other proteins, the modulation of which is seen 
as  a  great  opportunity  to  expand  therapeutic  possibilities  (Arkin  and  Wells,  2004; 
Gonzalez-Ruiz  and  Gohlke,  2006).  All  this  translates  in  an  urgent  need  for 
methodological developments that can expand the applicability and the throughput of 
techniques aimed at solving protein-ligand complexes. Developing one of such methods 
is the focus of this thesis. Below an overview of the state-of-the-art and current trends 
and  developments  in  the  field  is  given,  in  order  to  properly  frame  the  niche  and 
relevance of the approach herein developed. 
2.1  Protein-ligand  complex  structure  solved  by  experimental 
methods 
Despite  rapid  and  impressive  progress  in  other  techniques  such  as  cryo-electron 
microscopy  (Jiang,  et  al.,  2008),  X-ray  crystallography  and  NMR  remain  reference 
experimental  techniques  for  characterizing  macromolecules  and  their  complexes  at 
atomic resolution (Figure 2.3). 
In X-ray crystallography, crystals of proteins are irradiated with an X-ray beam, which 
due to the different electron densities it encounters in its way, scatters after crossing the 
crystal.  By  rotating  the  crystal,  multiple  scatters  from  different  perspectives  can  be 
collected and assembled so that a 3D picture of the internal structure of the crystal is 
inferred. The aminoacidic sequence of the protein must be known, so that the structure 
of the protein can be elucidated by fitting the protein atoms to the template generated 
from the observed electron densities (Ilari and Savino, 2008). X-ray crystallography is 
commonly acknowledged as a superior technique for obtaining high-quality structures, 
however, finding the optimal conditions for crystallization is typically challenging. By 
its side, NMR is a more versatile technique (Jahnke, 2007), since it can produce a larger 
number of observables from which to infer the structure of the macromolecule, among 
which J-couplings, NOEs, chemical shifts, relaxation rates, residual dipolar couplings 
are the most relevant (Clore and Gronenborn, 1998). The clear advantage is that finding Structure-based ligand design    11 
     
the  right  experimental  conditions  is  considerably  less  demanding  in  NMR  (Wider, 
2000). However, two critical limitations of NMR are first, the requirement of relatively 
high sample concentrations at which the protein must not aggregate. And second, due to 
the high number of signals, traditional NMR is limited to the study of proteins smaller 
than 10 kDa;  larger ones (30-40 kDa) require different  isotope labeling schemes to 
simplify the spectra. 
But despite the aforementioned current limitations, NMR for structural characterization 
of biomolecules is still a young technique, subject to intense research in its different 
components.  In  order  to  simplify  the  crowded  spectra  that  typically  big  molecules 
produce, selective labeling strategies have been developed to alternatively switch on or 
switch  off  specific  nuclei  (Goto  and  Kay,  2000;  Wider,  2005).  A  better  physical 
understanding of nuclear spin dynamics has permitted the development of new pulse 
sequences,  increasing  the  control  on  the  generated  NMR  signal.  A  remarkable 
breakthrough  in this  sense  has  been the  advent of TROSY spectroscopy (transverse 
relaxation-optimized  spectroscopy  (Fernandez  and  Wider,  2003))  which  has 
significantly  surpassed  the  protein  size  limitations  (Fiaux,  et  al.,  2002).  Also, 
experimental developments have permitted the practical exploitation of residual dipolar 
couplings, which are useful for the study of relative orientations of large domains of 
macromolecules (Bax and Grzesiek, 1993). Additionally, NMR not only has profited 
from experimental advances, but also from algorithmic developments: for example, in 
the tedious stage of sequential assignment of the observed signals (Guntert, 2003) or at 
the final stage of structural characterization, where the sometimes limited experimental 
data can be supplemented with refinement procedures based on modern force-fields and 
advanced sampling techniques (Chen, et al., 2004). 
This picture renders both techniques complementary rather than competing: both yield 
high quality structures, but each one observes different aspects of the structures. Most 
importantly, different experimental conditions requirements leave only one of the two 
techniques applicable, as will be described below. Structure-based ligand design    12 
     
 
Figure  2.3  X-ray  crystallography  (A)  and  NMR  (B)  are the  main  tools  for  solving 
biomolecular structures. X-ray methods fit the structure of the molecule to the 
observed diffraction pattern. NMR relies on a large collection of observed NOE, 
which subsequently is used with distance-geometry methods.  
2.1.1  Protein-ligand X-ray crystallography 
X-ray crystallography is the predominant and preferred method for solving structures of 
proteins and protein-ligand complexes. Approximately 85% of the structures deposited 
in the PDB at the time of writing have been solved by this technique (Berman, et al., 
2000).  X-ray  crystallography  can  be  applied  to macromolecules  in  a  large  range  of 
sizes,  providing  high  structural  resolution  and  even  the  position  of  ordered  water 
molecules that in many occasions mediate protein-ligand interactions (Scapin, 2006). 
Traditionally, protein-ligand complexes have been solved by co-crystallization, which 
typically yields a good-quality picture of the complex, but requires producing robust 
crystals  with  good  diffracting  properties  (Leach,  et  al.,  2006b).  This  is  the  most 
challenging  step of the whole process, particularly  if the experimental  conditions to 
obtain the protein-ligand crystals differ from the ones in which the crystal of the protein 
alone crystallizes, or the ligand is not soluble in the crystallization medium (Jhoti, et al., 
2007). In summary, a tedious, not always successful, series of trial-and-error attempts Structure-based ligand design    13 
     
results  for  each  new  protein-ligand  system  to  be  studied.  Challenged  by  these 
limitations, the worldwide structural genomics community has pushed research towards 
the development of robotics and liquid handling procedures, which eventually permitted 
an increased throughput in the crystal production (Kuhn, et al., 2002; Sharff and Jhoti, 
2003;  Weigelt, et al., 2008) by parallel testing  of  large  numbers of  conditions. The 
synergy of these technological advances with a technique called “soaking” constitutes 
the big success in bringing protein-ligand crystallography to a high-throughput level. 
In the soaking technique compounds (as single species or in mixtures) are incubated 
with pre-formed crystals of the protein, free or in complex with another ligand to be 
displaced  by the  binding of the  new one. This  permits that, once the crystallization 
conditions for a given protein have been optimized, large compound libraries can be 
tested in parallel, in principle. High-throughput crystallography by soaking has been key 
in  the  development  and  adoption  of  X-ray  aided  fragment-based  techniques  for  hit 
finding and ligand design. This is a very young approach to ligand design but already 
counts with a remarkable number of successes reported in the literature (Jhoti, et al., 
2007). 
One limitation though, is that the crystal form must be compatible with the binding of 
the ligand, i.e., the binding of the ligand should not break the crystal. Also, the binding 
site must be accessible for the ligand. As a further concern, it has been argued that in 
some cases the binding mode of the soaked ligands does not accurately correspond to 
the native binding mode, as the constraints of the pre-formed crystal prevent it (Zhu, et 
al., 1999; Hiller, et al., 2006). 
Apart  from  the  above  described  experimental  limitations,  X-ray  crystallography  in 
general is not free from being affected by artifacts. Crystal preparation, data collection, 
or coordinate placement during refinement can  affect and condition the  final results 
(Shoichet and Bussiere, 2000; Davis, et al., 2003; Acharya and Lloyd, 2005). If the 
system under study happens to be crystallization-resistant, NMR or theoretical methods 
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2.1.2  Traditional  (NOE-based)  NMR  for  studying  protein-ligand 
complexes 
As discussed in the introduction to this section, the study of protein-ligand complexes 
by NMR methods is nowadays seen as complementary to X-ray, rather than competing. 
“Traditional  NMR”  for  structural  characterization  of  biomolecules  relies  on  the 
geometric  information  that  can  be  derived  from  through-space  proton-proton 
correlations as measured via the nuclear Overhauser effects (NOE) (Wider, 1998) The 
NOE  is  the  phenomenon  by  which  spin  polarization  is  transmitted  from  one  spin 
population to another via cross-relaxation (Levitt, 2001). It has been established that for 
molecules with a molecular weight of more than 5 kDa, the intensity of a NOE between 
two protons is proportional to the inverse of the sixth power of the distance separating 
them  (Neuhaus  and  Williamson,  2000).  Accordingly,  NOEs  are  usually  observed 
between protons which are  not further than ~5  Å  from one another. Observing and 
assigning  an  adequate  number  of  NOEs  with  their  relative  intensities,  suffices  to 
generate highly determining number of distance restraints as to accurately define the 
structure  of  the  protein  (Wuthrich,  2001).  In  the  case  of  protein-ligand  complexes, 
despite the examples reported (Gargaro, et al., 1998; Moy, et al., 1999; Polshakov, et 
al., 1999a; Moy, et al., 2000), two limitations appear: first, observing and assigning 
NOEs in protein-ligand complexes does not provide the throughput required in drug-
design efforts; second, intermolecular protein-ligand NOE are not observed for ligands 
that bind weakly to the protein (Reibarkh, et al., 2006; Cavanagh, et al., 2007). 
The limitation of the throughput yield early attempts to simplify the standard method 
(Polshakov, et al., 1999b), but the real improvement in this respect comes when the 
structure of the target protein (unbound, or in complex with other ligands) is known. For 
example, in the NMR-DOC protocol (Pellecchia, et al., 2002), the idea is to apply the 
knowledge of the aminoacidic content of the binding site region to selectively label it 
for the NMR experiment. Assignment of residues in the binding site is subsequently is 
achieved  by  monitoring  chemical  shifts  perturbations  due  to  ligand  binding  or  by 
directly  measuring  observing  protein-ligand  NOEs.  Another  approach  is  based  on 
generating  a  large  number  of  candidate  ligand  poses,  then  back-calculating  the 
theoretical intermolecular NOE they would produce on protein amide groups (simple 
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(Bertini, et al., 2005). A  further refinement of this  idea overcomes the  necessity of 
assigning  all observed NOEs (Constantine, et al., 2006). From the generated  ligand 
poses  the  corresponding  theoretical  3D 
13C-edited, 
13C/
15N-filtered  HSQC-NOESY 
spectrum  is  calculated  and  by  using  a  fast,  deterministic  bipartite  graph  matching 
algorithm  the  prediction  is  compared  and  scored  with  respect  to  the  experimental 
spectrum.  
With respect to complexes in the weak binding regime, the most interesting in lead 
finding  and  optimization  stages,  instead  of  NOE,  attention  has  gone  to other  NMR 
observables,  including  chemical  shifts,  line  broadening,  transferred  NOE, 
intermolecular magnetization transfer or change in relaxation properties (Carlomagno, 
2005) These observables play the most important role in the study of protein-ligand 
complexes by NMR (Jahnke, 2007). However, since structures cannot be inferred as 
straightforwardly from them as in the case of complete NOE collections, they must be 
substantially  supplemented  with  theoretical  methods  that  automatically  generate 
plausible poses. Most typically, such a conformation generator is a docking program. 
Since  the  approach  described  in  this  Thesis  falls  in  exactly  that  category,  it  is 
convenient to first present what docking is and what current docking approaches are 
capable  of.  It  is  from  that  perspective  that this  work  has  been  done.  Consequently, 
NMR-based methods for structural studies of protein-ligand complexes binding in the 
weak regime are reviewed afterwards, under the appellative of “hybrid NMR-driven 
docking approaches”. 
2.2  Theoretical methods for predicting protein-ligand complex 
structures: docking and scoring 
2.2.1  Definition of protein-ligand docking 
While solving the structure of a protein-ligand complex fully by experimental method is 
the preferred way,  it comes together with  high  costs in time  and resources. This  is 
particularly  true  when  a  relatively  large  number  of  ligands  needs  being  studied.  In 
addition, it is not always possible to for example obtain good diffracting crystals of a 
protein-ligand complex. However, if the structure of the target protein (or a very close 
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computational methods is nowadays a widely accepted alternative and, in the case of 
large libraries, definitely a more efficient one. A very popular technique for such a task 
is the “docking and scoring” methodology. Given the structure of the protein and the 
putative  ligand,  the  docking  program  samples  millions  of  likely  interacting  modes 
between the two partners and scores them according to a defined objective function 
aimed at predicting the interaction energy. Eventually, the best scored pose corresponds 
to the best theoretical binding energy and, if the simulation went right, to the native 
structure of the complex in biological conditions. Reported docking programs amount to 
more than 60, combined with more than 30 scoring functions, according to a very recent 
review (Moitessier, et al., 2008). On average, they achieve up to 80% success rate in the 
task of placing a ligand back into its binding site (re-docking) when dealing with typical 
enzymatic targets, i.e., proteins with deep and well-defined binding sites. Such a rate 
deteriorates sharply in the case or flatter binding sites (Ferrara, et al., 2004; Warren, et 
al., 2006). 
Despite imperfections, docking has been applied with remarkable success in the past in 
the context of structure-based virtual screening (SBVS) approaches. There, large virtual 
compound libraries are docked to a given target, and the energy of the interaction is 
estimated. According to the interaction energies, compounds can be prioritized, thus 
orienting and concentrating the efforts of medicinal chemists on the most interesting 
compounds  for actual synthesis  and biochemical/biological testing. Precious time an 
resources are saved, this way, as illustrated, for example in a SBVS campaign in search 
of protein tyrosine phosphatase 1B. There, the prioritized set of ligands resulted in a 
1700-fold enhancement of the hit rate over random screening (Doman, et al., 2002). 
Some  other  success  docking  stories  have  been  collected  in  a  number  of  reviews 
(Kitchen, et al., 2004; Mohan, et al., 2005; Klebe, 2006). Together with hit-finding, 
docking  has  another  relevant  application  in  the  ligand  optimization  step.  Once  an 
interesting  binder  is  found,  efforts  concentrate  on  proposing  new  one  with  larger 
potency  or  better  selectivity  profile  or  simply  easier  chemistry.  By  analyzing  the 
interaction predicted by docking of proposed virtual compounds, informed decisions 
can be made with respect to which compounds must be synthesized first. It can become 
apparent that some candidates do not fit in the binding site or that others do not fulfill 
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A docking experiment requires four elements: the structure of the protein, the structure 
of  the  ligand,  an  automatic  generator  of  conformations  and  an  evaluator  of  those 
conformations (Figure 2.2). 
 
Figure 2.4 Docking consists of predicting how a ligand binds to its target protein and 
the energy of such interaction. Here, the binding of inhibitor Dmp323 to HIV-1 
protease is illustrated (PDB code: 1BVE). Adapted from ref (Kitchen, et al., 2004) 
The first docking programs considered both the protein and the ligand as rigid bodies 
(Kuntz,  et  al.,  1982),  which  permitted  a  complete  systematic  search  of  ligand 
orientations with respect to the protein, or even manual docking if one had sufficient 
experimental  data  supporting  the  proposed  solution.  Now,  ligands  are  always 
considered  flexible  and  even  some  implementations  allow  introducing  flexibility 
considerations of the protein. For example, version 4 of AutoDock (Morris, et al., 2009) 
as well as GOLD (Verdonk, et al., 2003) allow for explicit side chain flexibility. Other 
typical  implementation  of  flexibility  involves  considering  ensembles  of  protein 
conformations, experimental or theoretically simulated, as is the case of DOCK 3.5.54 
(Wei, et al., 2004). For a recent review on dealing with target flexibility see reference 
(Cozzini, et al., 2008). 
Considering both interacting partners as flexible generates a combinatorial explosion of 
possible  mutual orientations that renders the exhaustive search as  impossible. These 
methods include stochastic search as Montecarlo sampling or simulated annealing and 
heuristics  such  as  genetic  algorithms  or  swarm-based  optimization  algorithms.  The 
optimization typically occurs on the hypersurface that the guiding objective function 
describes: the energy landscape. To every relative orientation, corresponds a binding 
energy and the task of the algorithm is to find the global minimum. The aforementioned 
stochastic  methods  have  proven  useful  in  surmounting  likely  energetic  barriers  that 
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Objective/scoring  functions  are  simplified  attempts  to  efficiently  evaluate  the 
interaction  energy  of  a  given  protein-ligand  configuration.  Rigorous  energetic 
considerations of the interaction such as free-energy simulation techniques (Simonson, 
et  al.,  2002)  are  not  practical  for  the  purposes  of  docking.  This  results  in  docking 
solutions which are plausible, in terms of steric and chemical complementarity, but not 
native-like since important effects such as desolvation or translational and rotational 
entropy  are  neglected.  And  here  is  precisely  where  the  subtle  difference  between 
docking and scoring emerges. The difficulties in properly modeling the binding energy 
of interaction is reflected in the discrepancy between the relatively high success rates in 
docking and the limited ability of docking programs to correctly rank-order series of 
inhibitors according to their potency (Warren, et al., 2006). But both problems are not 
disconnected, and it is accepted that better docked structures provide better results in 
terms  of  binding  energy  prediction  (Velec,  et  al.,  2005;  Bertini,  et  al.,  2007). 
Consequently it is worth revisiting the idea that the docking problem is solved and that 
most efforts  must be put  in  improving scoring:  even  small  further  improvements  in 
docking, will translate in a benefit to the scoring problem. 
2.2.2  Scoring functions for protein-ligand docking 
Scoring functions fall typically into three categories: force-field-based, empirical and 
knowledge-based. 
In a force-field based function, the interaction energy between the ligand and the protein 
is decomposed as a sum of physics-based terms such as van der Waals and electrostatic 
contributions,  at  a  molecular  mechanical  level,  that  is,  simulating  atoms  as  single 
particles that interact pairwise. 
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Where Aij  and Bij are van der Waals parameters for the combination of atom type of i 
and  atom  type  of  j,  atoms  respectively  from  the  protein  and  the  ligand.  d  is  the 
interatomic distance and (dij) is the distance-dependent dielectric function. Structure-based ligand design    19 
     
Variations of such scoring functions are implemented in popular docking packages such 
as AutoDock (Morris, et al., 1998), ICM (Abagyan, et al., 1994) and DOCK (Meng, et 
al., 1992). The parameters describing each atom type are typically obtained from fitting 
to  experimental  quantum  mechanics  data.  Unfortunately,  these  parameters  were 
originally  formulated  to  model  the  systems  in  gas-phase,  neglecting  solvation  and 
entropic effects. Finally only one protein conformation is considered, so that the score 
of  a  given  ligand  pose  boils  down  to  considering  the  internal  energy  of  the  ligand 
(energy of the conformation) and the intermolecular energy of interaction, neglecting 
the internal energy of the protein. All these simplifications, although rendering a quite 
efficient  and  to  some  extent  accurate  description  of  the  protein-ligand  interaction, 
translates  into  a  limited  applicability.  The  challenge  to  describe  intermolecular 
interactions  efficiently  only  with  physics-based  terms  has  been  underlined  by  one 
simple estimation: the free energy difference between the best ligand that one might 
reasonably  expect  to  identify  using  virtual  screening  (potency,  ~50nM)  and  the 
experimental detection limit (potency, ~100 M) is only about 4.5 kcal/mol. The free 
energy contribution due to conformational factors alone for typical druglike ligands can 
be as large as this (Tirado-Rives and Jorgensen, 2006). In spite of that, this remains an 
active  field  of  research  (Huang  and  Jacobson,  2007),  and  has  found  interesting 
applicability not for docking itself but in re-scoring schemes which attempt to more 
finely understand protein-ligand interactions, once the structure of the complex is in 
hand (Wang, et al., 2001). 
Empirical  scoring  functions,  pioneered  by  Böhm  (Bohm,  1994),  consist  also  on  a 
weighted sum of terms, but these are not formally physically grounded.  
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Binding energy (Gbind) in this case is the sum of a hydrogen-bond (ionic and neutral) 
term, which has an angular () and a distance dependence (R), a hydrophobic effect 
term, as a function of the molecular surface area (Ahydrophobic) and an account for ligand 
rotational entropy, by means of considering the number of rotatable bonds in the ligand Structure-based ligand design    20 
     
(Nrotor). All terms are weighted (GH-bond, Gionic, Ghdrophobic, Grotor) empirically, from 
regression analysis against experimental data. G0 is a regression constant. 
These functions typically appear in popular docking packages such as GLIDE (Friesner, 
et al., 2004) and GOLD (Verdonk, et al., 2003). Although empirical scoring functions 
usually  appear  almost  consistently  amongst  the  most  accurate  ones  at  scoring,  one 
should not forget that their accuracy is compromised by the experimental data used in 
the  parameterization  and  that  the  training  set  of  protein-ligand  complexes  is  biased 
towards enzyme-inhibitor complexes where the ligand fits into a well-defined cavity. As 
discussed  below, this  indeed represent a  serious drawback when dealing with  small 
fragments or rather flat and large binding surfaces, as in protein-protein interfaces. 
The third class of protein-ligand scoring functions are the so called “knowledge-based” 
scoring  functions.  They  build  up  on  the  classical  statistical  physics  idea  that  the 
observed distributions of properties can be used to infer the potential that gave rise to 
the  distribution.  Their  first  uses  have  been  described  in  protein  folding  studies 
(Miyazawa and Jernigan, 1985), and the growing number of protein-ligand complexes 
deposited in public databases permitted the development of also protein-ligand binding 
potentials that are nowadays used in docking, being the most representative examples 
PMF (Muegge, 2000) and DrugScore (Gohlke, et al., 2000). The DrugScore equation is: 
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where Wij is a distance dependent pairwise potential, SAS correspond to the surface 
accessible area terms and  is an adjustable weight factor. 
The main caveat for knowledge-based scoring function is that they have been developed 
to  reproduce  experimental  structures,  rather  than  binding  energies,  which  somehow 
limits their applicability to that task. As empirical scoring functions, knowledge-based 
scoring functions circumvent the major limitations of force-field scoring functions, that 
is having to accurately describe the underlying physical phenomenon. Structure-based ligand design    21 
     
2.2.3  Current challenges and trends in protein-ligand docking 
In common docking benchmarking and evaluation, programs are presented with three 
already anticipated challenges of increasing difficulty: (1) binding mode prediction, (2) 
discrimination  of  binders  from  non-binders,  and  (3)  binding  energy  prediction.  As 
discussed above, the degree of success of state-of-the-art docking programs in each of 
these tasks deteriorates according to the respective difficulties. Furthermore, correctly 
predicting binding energy (3
rd goal) heavily relies on having good starting structures (1
st 
goal), that is, all three goals are interconnected, and deficiencies are carried on along the 
line. In a recent comprehensive evaluation of docking programs, it has been shown that 
for the first goal, success can range from 0% to 90% of the cases, depending on the 
program/protein target combination. With respect to the second goal, results vary from 
recovering 80% of active compounds in a SBVS campaign to consistent worse than 
random  performance,  which  raises  the  question  for  the  source  of  success  when  it 
happens. The last objective is “beyond all of the current docking methods” (Leach, et 
al., 2006a; Warren, et al., 2006). With this picture in sight the most sensible decision is 
probably taking docking for its merits as a tool for generating plausible protein-ligand 
complex  structures.  Later,  those  poses  are  considered  as  starting  points  for  further 
refinement with more sophisticated techniques, depending on the stage and needs of a 
given  project.  Of  course,  this  is  assuming  that  a  0%  to  90%  success  in  generating 
native-like structures is a convincing figure. It is certainly not for the cases in the low 
end, which appear to be challenging to all standard docking approaches. 
Why docking fails, when it does? Noteworthy, the difficulty of the “challenging cases” 
has been attributed to characteristics of the target binding site. In particular, a rather 
large binding site surface, different from the typical enzymatic pockets on which most 
of  the  current  docking  methods  have  been  trained  (Warren,  et  al.,  2006),  seems  to 
condition the success. In other words, success of current scoring functions appears to be 
highly  dictated  by  well  defined  binding  pockets,  which  effectively  constrain  the 
possibilities  to  place  a  given  ligand  inside.  This  reflects  the  limitations  of  current 
scoring functions and leaves docking out from what are nowadays probably the single 
two  most  promising  developments  in  drug  design:  1)  modulation  of  protein-protein 
interfaces  as  valid  therapeutic  target  (Arkin  and  Wells,  2004;  Gonzalez-Ruiz  and 
Gohlke, 2006) and 2) fragment screening (Hajduk and Greer, 2007). Structure-based ligand design    22 
     
As already advanced in the introduction, protein-protein interfaces are typically large 
and flat, compared to standard enzymatic binding pockets (Pettit and Bowie, 1999) (see 
Figure 1.1). By their side, fragments are in general too small for a binding site, thus 
providing few steric restraints for unambiguously docking them (Klebe, 2006) (Figure 
2.5). This thesis is focused on improving the ability of docking programs to generate 
native-like solutions, in particular in sight of these two particularly challenging cases. 
 
Figure 2.5. (a) Electron density showing multiple fragment-binding in an enzyme active 
site. (b) Core fragment chosen for synthetic elaboration showing possible growth 
vectors  to  two  adjacent  binding  sites.  Clearly,  the  fragment  is  not  sterically 
constrained  in  the  binding  site,  which  for  a  docking  program  supposes  a 
significant challenge. Adapted from (Ciulli and Abell, 2007) 
The  difficulty  to  develop  scoring  functions  that  perform  equally  well  across  many 
different protein families, regardless of their complexity and sophistication, is nowadays 
widely  accepted  (Kitchen,  et  al.,  2004).  For  this  reason,  researchers  tend  to  wisely 
choose the tool that works best for the system under study. If none is accepted as such, a 
suggested alternative has been to use several programs, pool all solutions together, and 
re-score by “consensus”. A higher degree of refinement involves effectively tailoring 
the docking scoring function to the protein or protein family of interest. This can be 
done for example with ligand-based information. If a collection of known binders is in 
hand, a binding-model can be derived to bias the scoring function (Fradera and Mestres, 
2004; Jansen and Martin, 2004; Radestock, et al., 2005). The peril of such approaches is 
that the new ligand is somehow forced to bind in a known fashion or to match known 
interactions, which in many cases is an acceptable assumption, but not if, for example, 
the aim was finding new scaffolds. Finally, if no collection of ligands is available, an 
appealing alternative is to incorporate directly measured experimental information from Structure-based ligand design    23 
     
the complex under study to restrain, guide, or postfilter docking solutions. A wealth 
source  of  such  information  is  NMR.  NMR  data  and  docking  programs  make  an 
excellent partnership, provided that the experimental observations can be efficiently and 
accurately modeled. Such has been the strategy pursued in this study: to combine NMR 
chemical  shift  perturbations  with  docking  to  improve  the  success  of  the  latter  and 
expand its applicability. Approaches sharing the same principles are reviewed in the 
next section. 
2.3  Hybrid NMR-supplemented docking approaches 
In a recent perspective on NMR in drug discovery published by Nature Reviews in Drug 
Discovery, experts underlined the  fact that NMR  is  not fully exploited  in  industrial 
settings  as  a  complement  to  X-ray  crystallography,  given  that  it  is  not  rapid. 
Interestingly, their opinion on a possible way to improve the situation was expressed as 
follows: “Our view is that the combination of molecular docking supported by limited 
NMR  experimental  constraints  could  represent  an  efficient  way  to  rapidly  gather 
information  on  ligand-target  complexes  without  full  structure  determination” 
(Pellecchia, et al., 2008). This opinion is solidly supported by the significant number of 
improvements and success reports that we are witnessing in the field. Nowadays, NMR 
can be applied in almost any stage of the ligand design process, from ligand binding 
detection (screening) (Coles, et al., 2003) and quantification of binding affinities (Klein, 
et al., 1999) to the most informative structural resolution at atomic level (Takeuchi and 
Wagner, 2006). See scheme in Figure 2.6. Structure-based ligand design    24 
     
 
Figure 2.6 Role of NMR in the drug design process, once the target has been validated. 
There are many NMR observables change upon binding and consequently are markers 
of the protein-ligand interaction. For example signals from the ligands, which do not 
have limitations on the size of the system studied nor need labeled samples. At the most 
basic level, changes in diffusion and relaxation rates can be used as binding reporters, as 
these properties are different for small ligands tumbling free compared to being bond to 
a large macromolecule (Hajduk, et al., 1997; Lin, et al., 1997) A more comprehensive 
list  is  collected  in Table 2.1. In principle, these signals are  not as rich  in terms of 
structural information as those from the protein-side, but they constitute the basis for 
many of NMR-based screening techniques currently available (Meyer and Peters, 2003). Structure-based ligand design    25 
     
Table 2.1 Comparison of NMR methods to obtaining structural clues about protein-
ligand complexes 
  Observable  Main limitation  Methods  Provides 
Protein / 
ligand side 
NOE  - Tight binders 
- Complex size limit 
- NOE observation  
- “Standard“ NMR 
-NMR-DOC 
 
Complex structure 
Ligand side  Intermolecular 
magnetization 
transfer 
- Fast exchange regime  - Transferred NOE 
- STD 
- WaterLOGSY 
- SAR by ILOE  
- CORCEMA 
Ligand binding 
epitope 
 
 
Complex structure 
  Cross-correlated 
relaxation rate 
- Fast exchange regime   - CCR rate  Conformation of 
the ligand 
 
Chemical Shifts  - Vast computational  
resources 
NMRScore  Complex structure 
Protein side  Chemical shift 
perturbations 
- Complex size limited 
- Assignments required 
- SAR by NMR 
- LIGDOCK 
- McCoy & Wyss’ 
approach 
-NMRScore 
 
Binding site 
location  / 
Complex structure 
Noteworthy, NMR-based screening compares favorably to biochemical screening, since 
no specific assay needs being developed and knowledge of the function of the protein is 
not needed. Even though NMR-screening is not the main focus of this work, it happens 
to be the case that some of the observables exploited there, have lately found application 
in  structural  characterization,  when  combined  with  computational  tools  (Meyer  and 
Peters,  2003;  Carlomagno,  2005;  Takeuchi  and  Wagner,  2006).  In  particular,  those 
based in the detection of intermolecular transfer of magnetization (transferred NOE) and 
chemical shifts perturbations. 
2.3.1  Uses of transferred intermolecular magnetization for structural 
characterization of protein-ligand complexes 
Molecules with low molecular weight have short correlation time and, consequently, 
show NOE values that range from very small negative to positive. Large molecules 
instead show strong negative NOEs. However, when the low-molecular-weight ligand 
binds to its target protein, it behaves as part of it and adopts the corresponding NOE 
behavior,  thus  showing  strong  negative  NOEs.  This  phenomenon  is  called  the 
transferred  NOE  (trNOE)  and  relies  therefore  on  the  differences  in  tumbling  times 
between free and bound small molecules. In principle it is possible to observe both Structure-based ligand design    26 
     
inter-  and  intramolecular  trNOEs:  the  former  ones  are  useful  for  defining  the 
conformation  of  the  ligand  in  the  bound  state  and  the  latter  for  determining  its 
orientation in the binding site (Meyer and Peters, 2003). 
Magnetization transfer is the basis of STD (saturation transfer difference) and can be 
observed between target and ligand in short-lived complexes through the NOE (Meyer 
and  Peters,  2003).  In  these  experiments,  appropriate  pulses  are  used  to  selectively 
saturate signals from the target, so that ligand spins in close-contact with the target 
experience  the  transference  of  magnetization  from  those  saturated  spins.  This  is 
consequently  reflected  in  a  decrease  of  their  line  intensities  in  a  1D-spectrum,  as 
depicted  in  Figure 2.7. Qualitatively, the technique  has  an unquestionable  value  for 
ligand screening. Additionally, some applications have been described where it has been 
shown that mixtures of ligands could be use likewise (Mayer and Meyer, 1999). 
 
Figure 2.7 Schematic representation of the STD experiment.  Ligand spins in close 
contact with the target receive part of the receptor spin saturation. Thus, ligand 
resonances  that  experience  a  decrease  in  intensity,  following  saturation  of  the 
target spins, identify the binding epitope of the ligand. Additionally, if the target 
has been selectively labelled, it is possible to establish distance restraints between 
specific ligand protons and residue types in the protein, which is the basis of the 
SOS-NMR approach (Hajduk, et al., 2004).  
The  quantitative  use  of  STD,  that  is,  considering  which  ligand’s  protons  are  more 
affected by the binding, reveals the binding epitope: that is the region of the ligand that 
is in closer contact to the protein (Maaheimo, et al., 2000; Haselhorst, et al., 2001). This 
information can  be quite precious when the  ligand  is rather  large, as  in the case of 
polysaccharides or peptides. One can define distance restrains between specific atoms in 
the  ligand  and  the  surface  of  the  binding  site  to  restrain  a  docking  simulation. 
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that violate them. Intramolecular ligand NOE, possibly combined with cross-correlation 
rates, serve also in the case of large ligands to fix it conformation (Carlomagno, 2005). 
Subsequently,  rigid-body  docking  can  be  performed,  which  is  a  considerably  less 
demanding task than fully flexible one. 
STD, combined with specific  labeling schemes, resulted  in the SOS-NMR approach 
(Hajduk, et al., 2004). There, different samples of the target protein are prepared, each 
perdeuterated in a specific residue. The magnetization transfer from each residue type to 
the ligand protons is revealed by the trNOE, which can be easily assigned to a given 
residue type. If the number of investigated residue types is enough, one can, first, define 
the binding site and, second, impose restraints between specific protons in the ligand 
and certain residue-types in the protein. This restrains are finally used for post-filtering 
docking-generated ligand poses to unambiguously define the structure of the complex. 
The  most sophisticated use of STD data  is presented by the CORCEMA (complete 
relaxation and conformational exchange matrix) approach (Jayalakshmi and Krishna, 
2004) STD data is used here to refine the structure of the complex. In brief, the method 
is  capable  of  predicting  the  STD  of  a  protein-ligand  complex.  Differences  between 
experimentally measured intensities and predicted ones for the proposed complexes are 
minimized during the search of the structure. An additional advantage claimed by the 
authors  is  that  protein  flexibility  could  be  easily  incorporated  into  the  refinement 
procedure. The development was done with theoretical data and concerns were raised, 
that  experimental  data  would  introduce  more  noise  and  thus  additional  degrees  of 
freedom  which  ultimately  would  hamper  the  convergence  to  a  single  structure 
(Carlomagno, 2005). However, successful applications have already been reported in 
the literature (Jayalakshmi, et al., 2004; Wen, et al., 2005). 
If  two  ligands  bind  concomitantly  to  a  protein  in  near-by  regions,  transference  of 
magnetization can also be observed between them directly, or mediated through target 
protons. This is called the inter-ligand Overhauser effect (ILOE) (London, 1999). This 
information cannot only be used for detecting binding, but also to establish structure-
activity-relationships, since both ligands could be linked together in a new molecule, 
thus producing a more potent binder. The technique aiming at such end has been called 
“SAR by ILOE” (Becattini and Pellecchia, 2006). A quantitative interpretation of the 
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Time-sequential protein-mediated ILOEs between competitive ligands that bind in the 
same binding site are exploited in the INPHARMA (interligand NOE for phamacophore 
mapping) approach. By analyzing the ligand areas that happen to be in contact with the 
binding site, it is possible to derive a pharmacophoric model (Sanchez-Pedregal, et al., 
2005), which in turn can be used to tailor a scoring function within a docking program.   
2.3.2  Methods  using  CSP  for  characterizing  protein-ligand 
complexes 
Transferred magnetization discussed above can be applied to deduce structure provided 
a sufficient collection of observations from which to derive restraints. Thus they can be 
described  as  indicators  of  pairwise  relative  positions.  By  their  side,  chemical  shifts 
perturbations (CSP) are very fine indicators of changes in the chemical environment of 
a nucleus as a whole, and therefore they are a more “genuine” parameter to be related to 
structure, despite difficulties to interpret them (Szilagyi, 1995). 
 The most popular application of CSP in SBLD is probably the SAR by NMR approach 
(Shuker, et al., 1996). Here, small molecular fragments that bind to the protein produce 
different patterns of CSP on this protein, depending on the place where they bind. This 
information is used to map the binding site: fragment A binds in subpocket S1, fragment 
B,  chemically  different,  in  subpocket  S2  and  so  on.  From  here,  fragments  can  be 
rationally combined through linkers into new compounds, which will be better binders 
by virtue of simultaneously targeting at least two favorable neighbor binding regions. 
Unfortunately, protein nuclei not directly involved in the binding do also experience 
CSP due to typical protein re-arrangements or flexibility, which introduces some noise 
in the detection. This, indeed, supposes a serious restriction to SAR by NMR: proteins 
must  not  undergo  significant  rearrangement  and  assignments  must  be  sufficiently 
comprehensive.  A  possibility  to  overcome  this  limitation  would  be  monitoring 
differences  in  CSP  for  closely  related  ligands,  expected  to  produce  similar  re-
arrangements (Medek, et al., 2000).  What the SAR  by NMR  lacks  is the ability to 
provide specific structural information about the complex. 
Probably  the  most  prominent  example  where  CSP  are  used  in  complex  structure 
elucidation  is  one  coming  from  the  more  challenging  protein-protein  docking  field. Structure-based ligand design    29 
     
Protein-protein  docking  is  particularly  challenging  because  the  number  of  possible 
relative  orientations  between  interacting  counterparts  is  several  orders of  magnitude 
larger than in the case of protein-ligand docking. For this reason pre-filtering or a bias 
integrated into the scoring function are the best options to obtain good results (and not 
postfiltering). In version 2.0 (May 2007), the HADDOCK program (Dominguez, et al., 
2003)  is  able  to  incorporate  various  experimental  data  from  NMR  (chemical  shifts, 
residual dipolar couplings (van Dijk, et al., 2005c), diffusion anisotropy (van Dijk, et 
al., 2006)) or from mutagenesis experiments. The approach has qualified successively 
amongst the most successful ones in the CAPRI competitions that evaluate the state of 
the art of protein-protein docking techniques (van Dijk, et al., 2005b). Technically, the 
restraints used by HADDOCK are ambiguous by definition. That is: it is known that a 
given  residue  must  be  in  the  interface  (because  their  CS  appear  perturbed)  but  the 
specific  counterpart  is  not  known.  These  qualitative  observations  are  modelled  by 
means of ambiguous interaction restraints (AIR) (Nilges and O'Donoghue, 1998). An 
AIR is defined as an upper-bounded intermolecular distance that must be fulfilled upon 
complex formation. However, it does not require a particular residue pair to fulfill it, but 
a subset of pre-selected possible pairs. This definition effectively restricts the search of 
possible orientations to a more tractable number, increasing the chances of success. 
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Residues defined as “involved in the interaction” are taken as pairs (i, k), one from each 
counterpart A and B, respectively. The distance is computed for every atom m in residue 
i from the first protein to every atom n of residue k in the second protein. In this way, as 
soon as two atoms are in contact the restraint is satisfied.  
Coming  back  to  the  protein-ligand  field,  inspired  by  the  ideas  developed  in 
HADDOCK, the group of Schwalbe has developed LIGDOCK (Schieborr, et al., 2005), 
which exploits CSP in a both ambiguous (Nilges and O'Donoghue, 1998) and semi-
quantitative  fashion  (weak,  medium,  strong,  with  only  strong  CSP  being  used)  as 
restraints for docking, in combination with a force field. The assumption is that largest 
CSP must correspond to direct protein-ligand contacts, and this way, it is possible to 
define  a  scoring  function  that  accounts  for  this  situation.  LIGDOCK  relies  on  the Structure-based ligand design    30 
     
concept of AIRs as HADDOCK does, but in this case AIRs are defined unidirectionally 
from  the  ligand  to  the  protein:  every  observed  (large)  CSP  constitutes  an  AIR. 
Calculations of the structure are done using CNS (Brunger, et al., 1998), which flexibly 
permits  defining  the  aforementioned  AIRs,  in  the  same  fashion  as  in  HADDOCK. 
Generated solutions are evaluated subsequently in terms of the AIR energy and van der 
Waals energy by means of a “selection plot”. Solutions that have either bad AIR energy, 
i.e. high number of distance violations, or bad interacting van der Waals energy are 
discarded. The approach  manages to effectively keep the  ligand  in the  binding  site, 
although  it  does  not  incorporate  any  information  for  discriminating  between  ligand 
orientations that occur within that binding site region... 
The pioneering quantitative use of CSP for this problem, to the best of my knowledge, 
has been reported by McCoy and Wyss (McCoy and Wyss, 2000) (also implemented in 
SDILICON (Moyna, 2003)). Their method exploits the ring-current effects that ligand 
with aromatic rings produce on the protons of the protein.  Aromatic rings not only 
constitute the main source of the contribution to the total CSP when present, but also 
produce  a  well-defined  pattern  of  up-  and  down-fields  on  the  surrounding  spins, 
depending on the relative position and orientation. Profiting from developments in the 
theoretical prediction of CS in proteins, such as the program SHIFTS (Osapay and Case, 
1991), the authors devised a protocol to align a ligand chemically similar to tryptophane 
to calmodulin. Consequently, they considered a probe tryptophane and generated a large 
number  of  bound  poses  of  it  to  calmodulin.  Using  SHIFTS,  they  predicted  the 
contribution to CS of the -carbon protons of the protein that each pose would produce, 
and compared those values with experimental ones. The largest agreement corresponded 
to the orientations closest to the native of the original complex. This demonstrated the 
usefulness of such an approach for aligning ligands to their target proteins on the basis 
of CSP. The  method has  been already  successfully applied  in the context of SBLD 
programs (Wyss, et al., 2004; Gorczynski, et al., 2007). A further development on the 
method has been presented recently, where the task of generating ligand conformations 
is  passed  to  the  protein-ligand  docking  program  GOLD  (Verdonk,  et  al.,  2003). 
Subsequently these starting poses are optimized according to their agreement to CSP 
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Very recently, a new method using a crude distance-dependent model for CSP called 
AutoDockFilter (Stark and Powers, 2008) has been reported. The authors assume that 
large amide CSP, negative or positive, must correspond to residues in close contact to 
the ligand. In a first step, large CSP are used to define the binding site area on which 
AutoDock (Morris, et al., 1998) docking is be performed. Ligand poses so generated are 
post-filtered according to the distance-dependent score in an AIR fashion: residues with 
largest CSP must have ligand atoms in closer contact than residues with smallest CSP. 
As in the case of LIGDOCK, such an approach ensures that the ligand remains in the 
binding site area, but does not provide information about how it orients once in there. 
Upon binding, both ligand and protein proton resonance signals are affected, resulting 
in CSP. Arguably, ligand signals are easier to follow and assign, and do not present 
limitations  on  system  size.  This  has  been  the  kind  of  information  exploited  in  the 
NMRScore approach (Wang, et al., 2004a; Wang, et al., 2004b; Wang, et al., 2007). 
There,  selected  CS  of  the  ligand  are  computed  at the  semi-empirical  MNDO  level, 
speeded up by using a “divide and conquer” methodology for diagonalizing the Fock 
matrix. The authors have shown that such an approach is superior in recognizing native-
like  conformations  of  protein-ligand  complexes  compared  to  standard  docking  and 
scoring approaches. Care must be taken in that symmetries in the ligand structure can be 
misleading, and for that additional experimental information from the protein side is 
required. All tests of this approach have been reported so far for one complex and, 
despite  being  promising,  its  applicability  at  the  scale  required  in  a  SBLD  program 
remains uncertain. Computational times are rather lengthy. Probably, ligand refinement 
and/or postfiltering would be, for the time being, the most appropriate application for 
this approach.  
The method to which this thesis is devoted shares many of the ideas of the previously 
presented, but taking them a step further in the approach. CSP are used quantitatively, 
so that not only protein binding regions are detected but also the actual orientation of 
the ligand with respect to the protein is directly obtained. The methods by McCoy and 
Wyss (McCoy and Wyss, 2000) or by Cioffi et al. (Cioffi, et al., 2008) do also use CSP 
quantitatively,  but  fail  to  acknowledge  that  the  different  CSP  for  different  HN  are 
predicted with uneven accuracy by empirical methods (Moon and Case, 2007). I will 
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functional  form  for  scoring.  Additionally,  it  has  been  assumed  that  current  docking 
engines are good enough at generating docking solutions, but as discussed above there 
are still  significant gaps, particularly when dealing with  large  binding regions as  in 
protein-protein interfaces or in fragment screening. This is a relevant issue to look at, 
considering that the large majority of the exposed methods use CSP information as post-
filtering,  i.e. relying on the ability of the docking engine to generate good docking 
solutions  beforehand.  Here  I  will  propose  an  implementation  that  incorporates  CSP 
information at docking time, in order to enhance the probability of generating native-
like  poses  with  respect  to  standard  docking.  I  anticipate  that  some  aspects  of  the 
problem are not going to be directly addressed in this work, as is the case of protein 
flexibility. However, the impact of not taking it into account will be evaluated. Theory and methods    33 
     
3  Theory and methods 
In what follows, the theoretical fundaments supporting the use of CSP in a protein-
ligand context will be exposed, accompanied by a description of the methods and the 
dataset of protein-ligand complexes used in deriving our CSP-driven docking scheme. 
The semi-empirical model applied by Case et al. in the program SHIFTS for predicting 
CSP in proteins constitutes the foundation of our formulation (sections 3.1 and 3.2). 
Molecular visualization lies at the core of molecular modeling, and plays also a crucial 
role for the understanding of the problem on which this thesis is focused. In section 3.3 
I discuss different visualization solutions proposed so far for facilitating comprehension 
of CSP effects of a ligand on a protein. I will explain the specific solution suggested in 
this work and justify its election. Concerning the actual development of the scoring 
function, I will explore in a first step several candidate mathematical formulations for a 
CSP-based scoring function in a post-filtering scenario. The statistical tools used for this 
evaluation (ANOVA analysis and coverage-error-plots) are described in section 3.4. In 
a second step, I will target the appropriate formulation of the hybrid scoring function, 
for which brief account on current docking failures will be exposed in section 3.5. The 
theoretical  reasoning  on  how  to  combine  the  knowledge-based  scoring  function 
DrugScore  with  CSP  information  is  described  in  sections  3.6  to  3.8.  Finally,  the 
reference  docking  method,  the  different  data  sets  used  along  this  work  and  their 
preparation are described (chapter 4). 
3.1  Chemical  shifts,  chemical  shifts  perturbations,  and  their 
use in structure elucidation 
The chemical shift (CS) of an atom is the most fundamental NMR observable (Levitt, 
2001). Because atomic nuclei have spin, when an external magnetic field B0 is applied 
on them, their precession frequency w0 is affected, proportionally to that magnetic field 
and as a function of the atom’s gyromagnetic ratio. 
  0 0 B      Eq. ( 5 ) 
Because the external field also induces currents in the electron cloud surrounding the 
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modulates the originally applied field at a local level. Thus, nuclei at two sites in the 
same  molecule  provided  they  are  surrounded  by  different  electronic  environments 
experience different changes in their respective precession frequencies, as is the case of 
protons in –CH3 group of ethanol and protons in –CH2 group of the same molecule. 
Since  this  effect  is  caused  by  the  induced  field  that  valence  and  bonding  electron 
produce, precisely those implicated in the chemical properties of the molecule, thus the 
name of chemical shifts (Levitt, 2001).  
Practically, chemical shifts are expressed in terms of the ration between the difference 
in  precession  frequency  of  the  target  nucleus  and  a  reference  and  the  precession 
frequency of that reference, in parts per million: 
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the  typical  references  are  protons  of  tetramethylsilane,  Si(CH3)4  for  experiments 
performed in organic solvents and for biomolecules those in the methyl groups of 2,2-
dimethyl-2-silapentane-5-sulfonic acid. 
Even  if  we  consider  the  nucleus  of  a  single  isotope  of  an  atom,  the  different 
magnetic/electronic  environments  in  which  this  nucleus  can  be  found  give  rise  to 
differences  in  frequency  of  resonance,  which  are  reflected  in  different  CS.  This 
phenomenon renders CS as an appealing parameter for studying the structure of matter. 
However, the challenge comes from the fact that the CS of a nucleus is a single number, 
and it is rather complicated to interpret it in geometrical terms when taking in isolation 
or as an absolute value. Fortunately, differences in CS to a reference state are easier to 
interpret. The phenomenon of a ligand binding to a protein causes a perturbation in the 
CS of the protein (also in those of the ligand). The unbound protein can be considered 
the reference state, to which CS in the complex can be compared, in order to deduce the 
orientation of the bound ligand. 
3.2  Empirical modeling of chemical shifts perturbations 
A change in the chemical environment of a nucleus results in a change in the field 
affecting  it  and  therefore  in  the  observed  chemical  shift  .  Empirical  models Theory and methods    35 
     
decompose the total observed perturbation in through-bond, due to covalently bound 
neighbor  atoms,  and  through-space  effects,  due  to  close-by  interacting  atoms,  non-
covalently bound (Szilagyi, 1995; Wishart and Case, 2001). 
  space through bond through           Eq. ( 7 ) 
through-space contributions include magnetic (electron ring currents and other magnetic 
anisotropies) and electrostatic (electric field, hydrogen bonds, solvation) effects. Nuclei 
most affected by these contributions are 
1H and 
19F atoms, since they are only bound to 
one other atom, while observed  of nuclei such as 
13C or 
15N are mostly determined 
by the covalent structure. This particularity,  makes these  nuclei  very  interesting  for 
deriving conformational restraints in biomolecular structure determination (Cornilescu, 
et  al.,  1999).  In  Table  3.1,  adapted  from  reference  (Wishart  and  Case,  2001),  the 
different contributions that give rise to the observed CS for active nuclei in proteins are 
collected. 
Table 3.1 Determinants of chemical shifts in proteins*. 
Attribute 
1HN 
15N  1H 
13C 
13C 
13CO 
Random coil  0  50  25  50  75  25 
Torsions (/)  0  0  50  25  10  50 
Torsions (/i-1)  25  25  0  0  0  0 
Side chain ()  5  0  0  5  5  5 
Side chain (i-1)  5  5  0  0  0  0 
Hydrogen bonds  25  5  5  5  0  5 
Ring currents  10  0  10  0  5  5 
Local charges  10  0  0  0  0  0 
Miscellaneous  20  15  10  5  5  10 
*Data given as % of the total effect. The decomposition is done for average values. For 
example it is clear that not all atoms/groups are involved in hydrogen bonds or are in 
the vicinity of aromatic rings. 
In the case of a ligand binding to a protein, the  experienced by any nucleus on the 
protein side can be calculated as the difference between the  in the complex and the 
free state: 
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where L denotes effects coming from the ligand and P effects coming from the protein, 
either  free  and  in  complex. It comes down to the direct effect of the  ligand  in the Theory and methods    36 
     
binding  site as a  source of perturbation plus  effects coming  from the protein  itself, 
which arise due to conformational rearrangements. If we assume no significant protein 
rearrangement upon ligand binding then 
Pcplx equals 
Pfree, which leaves only the effect 
of the ligand. Additionally, as I am considering the case where the ligand binds non-
covalently, there is no 
L
t-bond contribution, yielding: 
 
L
space t       Eq. ( 9 ) 
This  equation  can  now,  as  explained  before,  be  decomposed  into  magnetic  effects, 
coming  from  electron  ring  currents  of  aromatic  rings  and  other  magnetic  effects 
originated  by  chemical  groups  containing  double/triple  bonds  or  amide  groups  and 
electrostatic contributions: 
  m ele rc           Eq. ( 10 ) 
Where rc is the ring current contribution, ele is the electrostatic contribution, and m 
accounts for other smaller magnetic contributions. 
3.2.1  Ring current effects 
The ring current contribution is typically segregated from other magnetic contributions 
since when it is present, it accounts for the largest part of the observed chemical shift 
perturbation (CSP). Indeed, there are approaches described in the literature that rely 
only  on  this  contribution  for  orienting  ligands  with  respect  to  their  target  proteins 
(McCoy and Wyss, 2000). Theory and methods    37 
     
 
Figure 3.1 Ring currents around aromatic rings  in  solution  induced  by an external, 
static magnetic field. The shape of the ring current field is indicated by the red 
double-cone and by broken magnetic-field lines. The minus sign indicates that the 
NMR lines of hydrogen atoms located inside the cone in the three-dimensional 
protein structure are shifted “upfield”, whereas for atoms outside of the cone the 
shifts are “downfield”.  
The sign of the chemical shift affected by ring currents changes as a function of ring 
orientation, and the intensity of the shift does as a function of distance from the ring. A 
single ring on the surface of a protein produces significant perturbations (~0.1 ppm) for 
protons 7-10 Å from the ring (Case, 1995). Out-of-plane orientations with respect to the 
aromatic ring give rise to negative upfield shifts and in-plane orientations give positive 
downfield shifts (Figure 3.1). The change of the sign of the aromatic ring current as a 
function of ring orientation typically produces a pattern of positive and negative proton 
shifts when aromatic ligands interact with a protein surface. These patterns are very 
sensitive to translation and rotation of the ring. Formulas for computing each of these 
terms have been implemented in programs for CS prediction in biomolecules such as 
SHIFTS (Osapay and Case, 1991) or SHIFTX (Neal, et al., 2006), recently used  in 
predicting full protein structures from chemical shifts (Cavalli, et al., 2007), or in small 
molecules (Abraham, et al., 2000). The ring current contribution is generally modeled 
as: 
  ) (r IBG rc
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where r  is the vector from the observed proton to the aromatic ring,  ) (r G  is a geometric 
factor B collects constants that would yield the expected contribution from a benzene 
ring and I is the “ring current intensity” factor. The latter represents the ratio of the 
intensity expected for the ring in question relative to that of a benzene ring. Intensity 
parameters  for the aromatic systems  for this work were taken  from  Abraham et al. 
(Abraham,  et  al.,  2000;  Abraham  and  Reid,  2002).  The  geometric  factor,  from  the 
Haigh-Mallion theory (Haigh and Mallion, 1980), is expressed as : 
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Where ri and rj are the distances from ring atoms i and j to the proton and Sij is the area 
of the triangle formed by atoms i and j and the proton projected onto the plane of the 
aromatic ring, as depicted in Figure 3.2(A). The Haigh-Mallion model has proven its 
superiority to other empirical methods for calculating ring current effects, such as the 
Johnson-Bovey or the point-dipole approximation (Moyna, et al., 1998). 
 
Figure  3.2  Geometric  definitions  used  for  the  CSP  calculations.  (A)  Ring  current 
effects,  (B)  electrostatic  effects,  and  (C)  magnetic  effects  from  anisotropy 
generating groups. 
3.2.2  Electrostatic effects 
The electrostatic contribution  is typically computed as the projection of the electric 
fieldE

 calculated in vacuum onto the N-H bond, ) (N-H E

, as seen in Figure 3.2(B), 
where solvent effects are neglected. 
     i i i ele r q A N-H E A   cos ) / ( ) (
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A is an empirical constant, set it to -1.2·10
-12 esu
-1, as in reference (Osapay and Case, 
1991), qi is the partial charge of atom i. Distance ri and angle i between the proton and 
each source of charge are specified in Figure 3.2(B).  
3.2.3  Magnetic  effects  from  other  anisotropy-generating  chemical 
groups 
The  magnetic  anisotropy  effect  (Figure  3.2(C))  from  systems  with  -delocalized 
electrons (double / triple bonds in our case) is computed using McConnell’s equation: 
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where ii represents the axial component of the magnetic susceptibility tensor of the 
anisotropic group, R is the distance  from the proton to the anisotropic group, L0 is 
Avogadro’s constant and i is the angle between the i-axis and the vector connecting the 
proton with the chemical group. 
3.3  Visualization of CSP 
Information  visualization  is  defined  as  the  use  of  computer-supported,  interactive, 
visual  representations  of  abstract  data  to  amplify  cognition  (Card,  et  al.,  1999).  Its 
usefulness  in  biology  was  acknowledged  early  on  since  the  very  first  models  of 
Myoglobin and Hemoglobin were made available by Kendrew and Perutz, respectively 
(Kendrew and Perutz, 1948; Perutz, 1949), establishing the field of structural biology. 
Visual examination of the structural differences between the two molecules permitted 
an  accurate  understanding  and  interpretation  at  the  molecular  level  of  the  observed 
functional differences. Visualization is nowadays routinely used, as long as molecular 
structures or models are available. Visualization helps in integrating, understanding and 
rationalizing biological abstract data and supports rational planning of new experiments. 
Probably the  most  important application of  scientific  visualization  in general comes 
from the ability of human cognition to visually and instantaneously detect patterns and 
features in large datasets, which outperforms any known pattern recognition algorithm. 
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thinking  and  hypothesis  generation  and  serves  as  a  quality  control  for  detecting 
unexpected features. 
Approaches similar to ours which use structural information encoded in quantitative 
chemical  shifts  perturbations  (QCSP)  for  structure  elucidation  have  been  already 
published. In all these approaches visualization has been used as supporting means to 
explain how QCSP serve in delimiting binding sites and/or orienting ligands in those 
binding sites.  A summary of the  most relevant of such  visualization  is presented  in 
Figure 3.3. McCoy and Wyss (McCoy and Wyss, 2000) (Figure 3.3A) in describing 
their approach already discussed the drawbacks of the common CSP representation by 
surface mapping (Figure 3.3C) since SAR-by-NMR has been described. They pointed 
out  that  this  kind  of  representation  tends  to  overemphasize  shifts  of  large,  solvent 
exposed residues (Tyr, Lys, Arg, His) and under-emphasizes those of smaller residues 
such as Gly. Of course buried residues remained unseen. In addition, propagating the 
interaction to the whole surface of a residue is clearly misleading in those occasions 
where the interaction occurs only with the backbone of the protein. All this considered, 
they propose a visualization of the CSP as spheres centered on the actual atoms for 
which the CSP were measured. Up- and down-fields generated by the ligand, which can 
be structurally interpreted (e.g., relative orientation of an aromatic ring), translate in 
positive and negative CSP, represented by two different colors. Finally, differences in 
magnitude which reflect the distance from the source of the perturbation to the target 
atom are represented by proportional radii of the spheres. This kind of representation is 
also used by (Gorczynski, et al., 2007) (Figure 3.3B). The approach by Schieborr et al. 
(Schieborr, et al., 2005), focuses on a qualitative use of CSP, and, hence, only residues 
with the largest CSP are marked in red as in typical surface mapping. Surface mapping, 
despite  the  aforementioned  inconvenience,  has  the  advantage  to  show  the  steric 
constraints that the protein structure has and effectively defines the binding site. This 
information is not negligible, and combined with knowledge of the magnitude of the 
CSP can suffice for an expert to visually suggest or evaluate plausible binding modes of 
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Figure 3.3 Different molecular visualization styles seen in methods published that use 
QCSP for docking ligands into their partner proteins. In A (McCoy and Wyss, 
2000)  and  B  (Gorczynski,  et  al.,  2007),  positive  and  negative  QCSP  are 
distinguished  with  blue  and  red  colors  while  the  radii  of  the  spheres  are 
proportional to the respective QCSP magnitudes. In C (Cioffi, et al., 2008) protein 
surfaced  is  colored  following  a  red-green-blue  scale  on  a  per-residue  basis, 
mapping the absolute intensity (largest to lowest) of amide CS; D (Schieborr, et 
al., 2005) residues colored in red are those corresponding to the largest shifts.  
I  propose  to  use  the  best  ideas  from  both  visualization  styles  to  provide  a  more 
comprehensive  view  of  all  the  information  available:  structural  constraints  and 
localization and magnitude of the observed perturbations at the same time. These ideas 
have been collected and are exposed in the following section.  
3.3.1  Visualization methodology 
In this study, visualization is done with PyMOL (DeLano). CSP values are mapped onto 
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script data2bfactor.py from Dr. Robert L. Campbell (Campbell). The workflow is as 
follows: 
1.  PDBs are loaded into a new object in PyMOL. 
2.  Then, one creates a duplicate of the molecule (object called “exp”) to hold the 
experimental data.  
3.  B-factor  values  and  vdW  radii  of  all  atoms  in  the  exp  object  are  set  to  0. 
Experimental  data  is  loaded  by  means  of  the  data2b_atom  method,  from 
data2bfactor.py script. I modified this script to not only assign data to the b-
factor property but also adjust the vdW radius, which is set to the absolute value 
of the CSP. Then vdW radii are empirically scaled for optimum visualization. 
4.  Exp  is  then  represented  as  spheres.  Atoms  with  CSP  larger  than  the  pre-
calculated  average  are  colored  in  blue  and  those  with  CSP  lower  than  the 
average in red. Atoms set to the average CSPr are colored in green and their 
vdW radius is set to 0.2 Å. 
5.  Finally,  all  bonds  of  amide  protons  are  displayed  as  black  lines,  for  better 
perception of the extent of the assignment. Figure 3.4 shows a screenshot of the 
visualization used for discarding CSP unrelated to the direct effect of the ligand 
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Figure 3.4 Visualization of experimentally measured QCSP for the complex 1ecv on 
the protein. Red spheres represent negative CSP and blue positive CSP. The size 
of the balls are proportional to the absolute value of the QCSP. Green balls are CS 
which have been assigned but do not change significantly. The accumulation of 
CSP around the central cavity is used to visually discard distant QCSP which are 
not likely to be consequence of the presence of the ligand in their direct vicinity. 
In this case Asp-22, Phe-30, Val-34, Asp-53, Lys-58, Ile-57, Leu-204, Asp-229, 
Asp-236 and Ser-242 could easily be discarded. 
Representing the structure of the protein as a transparent surface makes apparent the 
deepest crevices (i.e., candidate binding sites) and steric constraints to which the ligand 
has to adapt to in order to bind the protein. CSP are mapped in the same way McCoy 
and Wyss suggest, that is: positive and negative CSP with two different colors and the 
spheres relatively scaled according to the absolute magnitude of the CSP. In addition, 
those CS which have been assigned but do not change upon ligand binding are also 
mapped as small green balls. This is useful as it helps identifying “forbidden” areas for 
the ligand. This visualization helps, additionally, to filter out CSP which are large in 
magnitude but are segregated from the “largest patch” of CSP, as they can be attributed 
to protein re-arrangement effects. Finally, CSP that would  not fit  in any reasonable 
binding mode hypothesis can be easily spotted and considered for further inspection as 
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Even though a human expert can visually assess potential solutions and easily decide on 
their  plausibility,  envisioning  these  solutions  from  the  unbound  protein  and  ligand 
structures  is  a  much  more  difficult  and  markedly  low-throughput  task.  Automatic 
computational methods such as molecular docking can, on the other hand, generate and 
evaluate millions of potential protein-ligand orientations, selecting the ones that fit best 
in terms of chemical and geometrical complementarity. It will be discussed below that 
despite its efficiency, molecular docking is also not a definitive answer to elucidating 
protein-ligand complex structures, since its accuracy can vary from case to case. This is 
particularly true for those cases where the ligand does not occupy the binding site area 
completely (see section 3.5 below). 
3.4  Measuring  agreement  between  experimental  and  back-
calculated  CSP:  assessment  of  candidate  scoring 
functions 
There are several approaches in the literature aimed at scoring docking poses according 
to their agreement with experimentally observed CSP. Typically an objective function is 
required (EQCSP) to be minimized. The straightforward functional form is based on a 
least-squared-minimization: 
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where  
{calc,obs}  stands  for  observed  and  calculated  CSP  respectively.  McCoy  and 
Wyss  (McCoy  and  Wyss,  2000)  already  realized  that  such  an  expression  could  be 
affected  by  the  fact  that the  ligand  does  not  always  bind  100%  to the  protein  and 
proposed a normalized variation, which also emphasizes the “fit of a pattern”: 
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Later,  Gorczynski et al. (Gorczynski, et al., 2007), who used the SDILICON program 
by Moyna (Moyna, 2003), which uses the same model as McCoy and Wyss, evaluated 
the  agreement  between  experimental  and  back-calculated  CSP  using  Pearson’s 
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based  on  the  RMSD  between  observed  and  back-calculated  CSP  and  defined  their 
objective function as: 
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   Eq. ( 17 ) 
where 
calc is the root-mean-square difference between the calculated and observed 
CSP values normalized by the absolute value of the observed: 
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and 
obs is the root mean absolute observed CSP: 
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In addition, an association constant scaling factor was included as a variable to scale the 
experimental CSP values to allow for ambiguity in the extent to which the protein is 
bound in the NMR experiment. The authors remarked that this approach optimizes the 
structure based on the relative changes in chemical shift rather than absolute values. 
Either  minimizing  normalized  least-squared-differences  or  Pearson’s  correlation 
coefficient  has  the  benefit  of  overcoming  the  problem  of  having  to  predict  correct 
absolute CSP values. This is important since it does not make the assumption that the 
protein binds fully to the ligand in the NMR experiment. According to this, our first 
candidate  objective  function was  Pearson’s  correlation  coefficient  between  observed 
and back-calculated CSP:  
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s stands for the standard deviations of observed and calculated CSP and N is the total 
number of pairs of CSP. 
A Pearson’s correlation based scoring scheme assumes that all CSP will be predicted on 
average with the same accuracy. This cannot be expected if an empirical model is used Theory and methods    46 
     
for  back-calculating  CSP.  Differences  of  exposure  or  localization  in  more  rigid  or 
flexible regions of the protein condition the individual accuracy of each predicted CSP. 
Most  importantly,  HN  involved  in  hydrogen  bonds  with  the  ligand  show  a 
disproportionate  error  in  prediction  compared  with  the  non-hydrogen  bonded  ones 
(Moon and Case, 2007). This renders a scoring function very sensitive to outliers, i.e., 
very  large  CSP  will  dominate the  calculation.  For this  reason,  I  decide  to  also test 
Kendall’s  correlation (Kendall, 1938), which is a robust alternative to Pearson’s: 
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where n is the number of experimental and computed CSP pairs and P is the number of 
concordant pairs. A pair of experimental values (xi, yi) and a pair of computed values 
(xj, yj) is concordant if sign(xj – xi) = sign(yj – yi). The values of  go from -1 (perfect 
ranking disagreement) to +1 (perfect ranking agreement) and pass through 0, which 
denotes an independence of rankings. 
Both Pearson’s (Eq. 20) and Kendall’s correlation (Eq. 21 ) functional forms will be 
considered and assessed as candidate objective function for scoring ligand poses with 
respect to the agreement between experimental and calculated CSP. 
3.4.1  ANOVA analysis 
In order to assess the discriminatory power of the proposed scoring schemes (Pearson’s 
correlation  and  Kendall’s  correlation)  I  performed  an  analysis  of  the  variance 
(ANOVA). This kind of analysis for scoring functions evaluation has been described by 
Seifert (Seifert, 2006). As explained by this author, ANOVA is applied to determine the 
proportion of the variability within the observed scores that is due to the scoring method 
itself  as  opposed  to  variability  caused  by  random  errors. Figure  3.5  illustrates  how 
native-like solutions score sufficiently differently from decoys in both an ideal and a 
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Figure 3.5 Score distributions  for an  ‘ideal’  scoring  function (left) and a  ‘realistic’ 
scoring function (simulated data). In the first case, native-like poses (‘ligands’ in 
the  legend)  score  sufficiently  differently  from  decoys.  In  a  realistic  scoring 
function  there  is  some  overlap  in  the  scores,  which  results  in  false  positives: 
identification  of  decoys  as  native-like  solutions.  Figure  adapted  from  (Seifert, 
2006). 
The ANOVA analysis departs from the null hypothesis that there is no difference in the 
scores  between  native-like  poses  and  geometric  decoys.  The  rejection  of  this  null 
hypothesis indicates that the scoring function is indeed able to discriminate between 
native-like poses and decoys, at a given significance level. The independent variable of 
the analysis is the assignment to the native-like pose group or the decoy group (p=2; 
i=1…p).  N  and  ni  denote  the  total  number  of  poses  (m)  per  group,  respectively.  I 
perform our analysis following the seven steps described (Seifert, 2006): 
1.  First, I computed the following sums of scores (s): 
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2.  Then, the total sum of squares Stot=S2-S1, and Streat=S3-S1, which measures the 
variability due to the scoring method is computed. Serror=S2-S3 accounts for the 
variability due to random errors. 
3.  The degrees of freedom for each sum are dftot = N-1, dftreat = p-1, and dferror = 
N-p, respectively. 
4.  The corresponding variances are calculated dividing the sum of squares by their 
corresponding degrees of freedom. Theory and methods    48 
     
5.  Finally, measures for the discrimination of the two groups by a scoring method 
are  given  by  the  coefficients  
2=Streat/Stot  and  
2=(Streat-(p-1)·)/(Stot+error). 
Coefficient 
2 is the fraction of the variance within the actual data set explained 
by  the  scoring  function.  A  weak,  medium  and  strong  effect  of  the  scoring 
function in discriminating between native-like poses and decoys is characterized 
by 
2 values of  1%, ~6% and 14% respectively. 
3.4.2  Calculations framework 
The aforementioned analysis is done on a comprehensive set of decoys and native-like 
solutions, described below. The CSP scores for each pose are computed in using in-
house developed python scripts, which constitute an extension of the PDB libraries from 
the  Biopython  package  (Hamelryck  and  Manderick,  2003).  Statistical  analysis  are 
performed within R (Ihaka and Gentleman, 1996). 
3.5  Limitations of current protein-ligand docking approaches 
Protein-ligand docking, the problem of given the structure of a protein and a ligand, 
finding the right binding mode, has had a big impact in rational drug design, but is still 
an  unsolved  problem.  There  are  three  the  main  applications  of  docking:  1)  binding 
mode  prediction  of  known  ligands,  2)  identification  of  new  ligands  through  virtual 
screening, and 3) predicting binding affinities of related compounds. These applications 
build on another, and thus constitute an increasing level of difficulty to get them right. 
This work is devoted to improve success with respect to the first application. 
Binding mode prediction has been the most successful docking application since the 
inception of the method. All three main classes of scoring functions (force field-based, 
knowledge-based and empirical ones) achieve success rates between 70 – 90%, but this 
is target dependent. This means that some combinations of scoring schemes work better 
for some targets (Stahl and Rarey, 2001; Schulz-Gasch and Stahl, 2003; Ferrara, et al., 
2004; Warren, et al., 2006). 
Docking involves two problems: searching and scoring. During the first years, docking 
was typically done considering a rigid receptor and a rigid ligand, which permitted an 
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the combinatorial explosion that occurs even if only ligand bonds are treated rotatable. 
This is a more realistic assumption, since the bioactive conformation doesn’t need to be 
equal to the most stable of the free ligand. Needless to say that flexibility of the protein 
should also be accounted for, how to deal with it correctly remains a field of intense 
investigation (Cozzini, et al., 2008). For the case of a flexible ligand to be docked to a 
rigid target, the search problem is considered to be solved. That is, current algorithms 
and increasing computing power make it possible to sample relevant binding modes of a 
ligand to a protein, i.e., those which are geometrically and chemically complementary. 
But search is not absolutely decoupled from scoring: since the search is an optimization 
problem that occurs on the hyper-surface defined by the scoring function, a “rugged” 
landscape of it increases the challenge of the finding the global minimum. Therefore, 
the ideal scoring function should have 1) a global minimum that coincides with the 
native  solution  of  the  complex  and  2)  a  funnel-like  smooth  shape  that  permits  this 
solution to be found. 
The  lack  of  correspondence  of  the  energy  function  minimum  with  the  native 
conformation gives raise to so-called “decoys” (false positives) (Graves, et al., 2005). 
These are solutions which are physically reasonable but incorrect, with respect to the 
known native structure. Interestingly, the existence of decoys does not prevent docking 
programs from sampling the native solution: the problem is typically that this solution is 
not located at the minimum. Decoys are useful for understanding the weaknesses of the 
scoring function, since they tell about critical contributions of the scoring function that 
are not being taken into account or have been overweighed. Consequently, they serve as 
the basis for further improvements. Such an analysis is presented in the next section. 
3.6  Reference method: Docking with DrugScore-only 
DrugScore is one of the most reliable scoring functions for identifying (Gohlke, et al., 
2000) and generating (Velec, et al., 2005) native-like docking solutions (Wang, et al., 
2003; Ferrara, et al., 2004), with success rates of about 75%. Still, docking based on 
only DrugScore may fail due to, e.g., not considering interactions to structural waters, 
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Throughout this work the conformational search engine of AutoDock 3.0.5 (Morris, et 
al., 1998) was used as a framework for development to which DrugScore potentials 
grids  were  plugged-in  for  scoring.  From  the  several  search  schemes  available  in 
AutoDock I chose the Lamarckian genetic algorithm (LGA), which is considered as the 
most efficient alternative (Morris, et al., 1998). DrugScore grids, with 0.375 Å spacing, 
were calculated and scaled as previously described (Sotriffer, et al., 2002). Grids are 
centered in the binding site and cover a volume that extends at least 7 Å beyond any 
ligand atom in the native bound conformation. In the cases where an iodine atom was 
present in the ligand, it was substituted by bromine, as no potentials for iodine atoms 
were available in DrugScore. 
3.6.1  Evaluation of docking success 
A standard docking job consisted on 100 independent docking runs for each protein-
ligand  complex  (initial  population:  150;  termination  criterion:  1  million  energy 
evaluations; mutation and cross-over rates: 0.8 and 0.02 respectively; elitism: 1; local 
search  frequency:  0.06;  maximum  iterations:  300).  After  the  100  runs  have  been 
completed,  ligand  poses  within  1.0  Å  threshold  are  automatically  clustered  by  the 
standard  procedure  implemented  in  AutoDock.  That  is,  the  best  (lowest)  scored 
conformation  acts  as  a  seed  to  construct  the  first  cluster.  All  structures  from  the 
remaining 99 runs within 1.0 Å RMSD are clustered together with this one and removed 
from the starting pool of solutions. The process continues iteratively with the not-yet 
clustered until all 100 solutions have been assigned to a cluster. Solutions with RMSD 
smaller  than  or  equal  to  2.0Å  to  the  native  crystal  conformation  (reference)  are 
classified as native-like (Cole, et al., 2005). Conformations with RMSD larger than 2.0 
Å are classified as non-native-like solutions. Docking is considered successful if the 
largest  cluster  of  solutions  contains  at  least  one  native-like  solution.  Additionally, 
unsuccessful dockings according to this criterion are further divided into two groups: 
those that generated native-like solutions and those that did not. 
3.7  Hybrid scoring: mixing DrugScore with CSP 
Once the most appropriate scoring scheme with respect to CSP is established, our aim is 
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docking scenario. In order to combine both contributions a reasonable solution is to 
proceed  as  in  biomolecular  structure  elucidation  protocols  (Jack  and  Levitt,  1978; 
Brunger and Nilges, 1993), defining a hybrid energy function that must be minimized: 
  QCSP QCsP DS hybrid E E E      Eq. ( 22 ) 
In our case EDS (i.e., DrugScore) accounts for “general knowledge” about protein-ligand 
complexes, EQCSP for the specific data observed for the complex under study, and QCSP 
is an empirical weight to be determined. The weighting of the EQCSP contribution will 
reflect the user’s “confidence” on the experimental data and the accuracy of the model 
to back-calculate it. This will vary from situation to situation. In biomolecular structure 
elucidation,  for  example,  the  most  rigorous  quantitative  method  to  determine  the 
optimal  weight  is  complete  cross-validation  (Brunger,  1992)  or  Bayesian-based 
methods (Habeck, et al., 2006), both incurring in large computing times and relying on 
rather  complete  experimental  data  collections.  These  approaches  are  thus  not 
transferable to the case presented here since real data sets are typically not that complete 
and efficiency must be kept. 
Empirical scoring functions for docking, pioneered by Böhm (Bohm, 1994), share a 
similar spirit with the hybrid scoring presented here. There, the assumption is that the 
ligand  binding  energy  can  be  decomposed  as  a  weighted  sum  of  uncorrelated 
physically-based terms (vdW term, electrostatics, hydrogen bond effects, etc.). In that 
case,  the  weights  are  determined  from  regression  analysis  using  experimentally 
determined  binding  energies  and,  potentially,  X-ray  structural  information.  The 
resulting scoring functions depend on the molecular data sets used to perform regression 
analyses and fitting, which often yields different weighting factors for the various terms. 
This approach for finding the appropriate weighting cannot be applied to the hybrid 
scoring  scheme  because  there  is  no  experimental  correlate  to  the  pseudo-energy 
computed. 
The strategy followed departs from the analysis of the docking “failures”. I assume that 
the docking program is able to sample native-like solutions (Leach, et al., 2006a), but in 
some cases, due to a varied number of small inaccuracies, is unable to pick the right 
one.  This  yields  a  “likely”  solution  in  terms  of  geometry  and  favorable  chemical 
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different from it, which is why it is called a decoy (Graves, et al., 2005). This scenario 
is depicted in Figure 3.6, where the concept of the “inverse” energy gap, the scoring 
difference between a decoy and a native-like solution, is also illustrated. I anticipated 
that analyzing differences in EDS and EQCSP contributions between decoys and native-
like solutions, respectively, will lead to appropriate bounds for the weighting factor.  
 
Figure 3.6 The EDS inverse energy gap. Docking failures (decoys) typically occur in 
less  accessible  regions  of  the  conformational  space  (continuous  line).  The 
expected effect of introducing the EQCSP contribution is to “close” the access to 
those solutions  while  leaving open the access to the native-like  solutions. The 
challenge is to appropriately weight this latter contribution because a very low 
weight  would  not  discard  the  DrugScore  decoys  and  too  high  a  weight  could 
eventually discard the native-like solutions. 
I therefore studied the distribution of EDS and EQCSP gaps in a comprehensive data set, 
consisting  of  70  protein-ligand  complexes  containing  aromatic  rings  out  of  85 
complexes  of  the  Astex  diverse  set  (Hartshorn,  et  al.,  2007).  As  detailed  below,  I 
performed standard DrugScore docking, consisting in 100 simulations for each protein-
ligand complex. Out of each of these 100 simulations, according to the different results, 
complexes can be classified in three groups: those where the top-ranked solutions are 
native-like, those where native-like solutions were generated but these do not get the 
best score, and thus decoys are also present, and cases where only decoys and no native-
like solutions were generated. 
In order to analyze the respective EDS gap for each complex between decoys and native-
like solutions it is only possible to study those cases from the second group, where both 
species decoys and native-like solutions, were generated. Theory and methods    53 
     
For analyzing the EQCSP gap, first I computed CSP of HN protons induced by the bound 
ligand, because no experimental CSP is available for the Astex diverse set. EQCSP is a 
correlation coefficient, and thus  its values are  limited  between -1 and +1. This  is a 
fundamental  difference  to  EDS  where  such  theoretical  limits  do  not  exist  and  each 
complex behaves differently. For this reason, in the case of the analysis of the EQCSP gap 
it  is acceptable to consider all cases,  including  those where either  no decoys or no 
native-like solutions were generated. 
Analyzing  how EQCSP scores behave with respect to the RMSD to native-structures, 
provides  and  additional  insight  on  the  sensitivity  of  the  scoring  function  to  small 
conformational changes. 
From the differences in both gaps, different weighting regimes will be proposed and 
explored. 
3.8  QCSP-steered docking 
In order to test the different candidate scoring functions and weighting regimes, the 
original AutoDock code was extended to include the contribution from the experimental 
CSP  (EQCSP)  in  a  hybrid  scoring  scheme  as  in  Eq.  (  22  )  (see  Appendix  I  for 
implementation and usage). Practically, the docking proceeds as a standard AutoDock 
run (see below), generating and evaluating potential protein-ligand configurations. For 
efficiency, only if a generated configuration has a favorable EDS interaction energy, the 
EQCSP contribution is computed. The total time required for a docking with our hybrid 
scoring scheme increases linearly by a factor of ~ 3 with the number of aromatic rings 
considered. As an example, a single docking run of 1a9u (4 aromatic rings) takes 14 
minutes  on  an  Intel  Pentium D  2.80  GHz  CPU,  whereas  docking  without  the  CSP 
information requires ~ 1 min. 
Docking with QCSPScore was performed using the same grids as in DrugScore-only 
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4  Data set description and preparation 
Two  different  datasets  were  used  in  this  study,  the  first  one  for  the  theoretical 
development  of  the  scoring  function  and  the  second  one  for  validation  with  real 
experimental data. 
4.1  CSP Theoretical data – training set 
The development data set I chose is the subset of the Astex diverse set (Hartshorn, et al., 
2007) that contains ligands with aromatic rings (70 out of 85 complexes). The Astex 
dataset has been assembled considering high quality structures from the PDB. Ligands 
are all drug-like, and proteins are all drug-discovery or agrochemical targets. No target 
is represented more than once. PDB codes for the 70 complexes are: 1gpk, 1hnn, 1hp0, 
1hq2, 1hvy, 1y6b, 1r58, 1sg0, 1sj0, 1t40, 1t46, 1tz8, 1u1c, 1unl, 1uou, 1v0p, 1v48, 
2br1, 1n46, 1v4s, 1vcj, 1w2g, 1p62, 1hwi, 1j3j, 1k3u, 1ke5, 1kzk, 1lpz, 1lrh, 1nav, 
1of1, 1of6, 1opk, 1oyt, 1p2y, 1q1g, 1q41, 1q4g, 1r1h, 1xoz, 1yqy, 1yv3, 1ywr, 2bsm, 
1uml, 1ygc, 1x8x, 1r9o, 1gm8, 1s3v, 1z95, 1xoq, 1ia1, 1l2s, 2bm2, 1meh, 1pmn, 1ig3, 
1t9b, 1xm6, 1jje, 1yvf, 1mzc, 1g9v, 1jd0, 1owe, 1tow, 1n2v, 1oq5. 
4.2  CSP Experimental data – test set 
The experimental set was limited to the three protein-ligand complexes already studied 
by Schieborr et al. (Schieborr, et al., 2005) (PDB: 1ecv, 1a9u and 1ydr) in the context of 
the development of a CSP-based method for solving protein-ligand complexes. Data 
was kindly provided by these authors. A crystal structure is available in the PDB for 
each case. The extent of CSP assignments in the binding site varies from 30 – 40% for 
1ydr and 1ecv to 75% for 1a9u. All three proteins experience some re-arrangement upon 
ligand binding. The RMSDs from free to bound structures range from 0.73 Å in the case 
of PTP1b to 2.11 Å in the case of PKA, where the enzyme changes between “open” and 
“closed” forms (Table 4.1). Additionally, DrugScore-only docking did not succeed in 
any of the three cases, making possible a better evaluation of the benefits of introducing 
CSP for guiding docking. 
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Table 4.1 Data set used for validation 
Ligand  PDB code
1  Rmsd
2 
NH
O
OH
O
O H O
I
 
1ecv (PTP1b)  0.73 (1pty)  
N
H
N
N
F
S
C H3
O
 
1a9u (p38)  1.01 (1p38) 
N
S
O
O
N
N
H
CH3
 
1ydr (PKA)  2.11 (1cmk) 
1 The protein name is given in parentheses. 
2 Rmsd between holo and apo structure, computed for all atoms of residues within 7 Å 
from the ligand. In Å. The PDB code of the apo structure is given in parentheses.  
4.3  CSP data preparation 
From  the  set  of  available  HN  CSP  for  each  complex,  values  within   1  standard 
deviation from the average were considered as noise arising from the digital resolution 
of  the  spectrometer.  Yet, these  signals  still  provide  some  relevant  information  with 
respect to the orientation of the ligand because they indicate areas not affected by the 
binding.  Thus,  they  were  not  discarded  but  re-set  to  the  average  CSP  value.  Non-
transformed QCSP are visualized in the context of the protein structure (see below) in 
order to delimit the binding site area and discard isolated CSP presumably originating 
from  protein  re-arrangements.  Table  4.2  summarizes  the  actual  CSP  used  for  each 
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Table 4.2 Summary of HN CSP considered in the calculations with experimental CSP 
reference data 
PDB 
code 
Exp. 
CSP
1 
Signifi
-cant 
CSP
2  
CSP set 
to avg.
3  Discarded CSP
4  CSP finally 
considered
5 
Binding 
site
6 
1ecv  82  20  62 
Asp-22, Phe-30, 
Val-34, Asp-53, 
Lys-58, Ile-57, Asn-
68, Leu-204, Asp-
236, Ser-242 
72  7/21 
             
1a9u  193  20  173 
Gln-11, Phe-42, 
Arg-57, Asn-100, 
Gly-219, Ile-297 
187  17/22 
             
1ydr  137  14  123 
Glu-64, Gln-84, 
Lys-111, Ala-304, 
Glu-346 
132  11/30 
1 Total number of experimental HN CSP available. 
2 Number of experimental HN CSP that deviate by more than one standard deviation 
from the average CSP over all HN nuclei. 
3 Number of experimental HN CSP whose value was set to the average CSP over all HN 
nuclei. 
4 Number of experimental HN CSP that were not considered in the calculation, although 
they deviate by more than one standard deviation from the average CSP over all HN 
nuclei. See Materials and Methods section for further explanation. 
5 Number of CSP finally considered in the docking. 
6 Number of HN within 7 Å of the ligand in the native structure that have CSP assigned 
and total number of HN within 7 Å of the ligand in the native structure. 
4.4  Protein and ligand preparation for docking 
The  Astex  diverse  set  was  obtained  directly  from 
http://www.ccdc.cam.ac.uk/products/life_sciences/gold/validation/astex_diverse/. 
Proteins in mol2 format were converted to PDB using Openbabel (Guha, et al., 2006). 
The ligand-bound protein complexes used for the experimental validation were obtained 
from the PDB. In both cases proteins were protonated with REDUCE (Word, et al., 
1999). This step is needed to determine the position of amide protons for the evaluation 
of  EQCSP;  DrugScore  only  considers  heavy  atoms.  DrugScore  grids  were  calculated 
using a grid spacing of 0.375 Å. The potential values were then scaled as previously 
described (Sotriffer, et al., 2002). Grids are centered on the binding site and cover a Data set description and preparation    57 
     
volume  that  extends  at  least  7  Å  beyond  any  ligand  atom  in  the  native  bound 
conformation. 
Ligands were converted to mol2 format with PRDRG (Schüttelkopf and Aalten, 2004). 
Atom  types  and  AM1-BCC  partial  charges  were  calculated  and  assigned  using 
ANTECHAMBER (Wang, et al., 2006). In the  case of 1ydr, an  iodine  atom  in the 
ligand was substituted by bromine, as no potentials for iodine atoms were available in 
DrugScore.  All  rotatable  bonds  were  defined  as  active  torsions  in  the  AutoDock 
context. Ligands were visually inspected to detect aromatic rings. These groups were 
listed  together  with  their  corresponding  intensities  (see  empirical  model  for  CSP 
computation above) in an additional input file by referring to the atom numbers in the 
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5  Results and discussion 
5.1  General strategy 
The aim of this project is to develop and validate an improved scoring function for 
docking through the use of experimentally measured CSP. On the one hand, state-of-
the-art docking programs are able to sample native-like solutions. However, all scoring 
functions, on a target-dependent basis, may fail to prioritize these native-like solutions 
over non-native-like ones (Warren, et al., 2006). On the other hand, a fully experimental 
approach is too cost-ineffective, particularly in a setting where throughput is a concern. 
The approach presented here seeks a compromise between both scenarios of efficiency 
with low accuracy and accuracy with low efficiency. The goal is to improve docking 
success  rate  by  supplementing  it  with  easily  obtainable  sparse  experimental  data 
(QCSP). 
The  proposed  scoring  function  is  a  linear  combination  of  QCSP  data together  with 
DrugScore in a straightforward hybrid scoring strategy QCSP QCSP DrugScore hybrid E E E    , 
which I call QCSPScore. There the global score of a given ligand pose Ehybrid is the 
original DrugScore score EDrugScore plus a weighted term accounting for the agreement 
between experimentally measured CSP and theoretical CSP that the pose would produce 
on the protein. This simple formulation opened up, however, two important questions: 
  how to measure the agreement between experimental and theoretical CSP? 
  how to weight the experimental data? 
In section 5.3 I address the first question. Using the data set of native-like and decoy 
geometries generated in a preliminary step (section 5.2) and the empirical model for 
back-calculating CSP described in the theory chapter, I tested two scoring schemes: 
Pearson’s and Kendall’s correlation. 
The weighting of the experimental contribution is established through an exhaustive 
evaluation of what I defined as the “DrugScore inverse energy gap” between decoys and 
native-like solutions, together with their average scoring differences  in EQCSP terms. 
Results from this study are reported and discussed in sections 5.4 and 5.5. The resulting Results and discussion    59 
     
candidate weighting schemes are applied in re-docking experiments performed on the 
Astex dataset, reported in section 5.6. 
The final step of the development consisted in translating the conclusions obtained from 
the  training  set  to  the  evaluation  set,  comprised  of  the  three  cases  for  which 
experimental data was available (section 5.7). This final evaluation served not only to 
assess the transferability of results derived from theoretical data, but also to analyze and 
assess the impact of limitations one faces in a real case situation, such as: the limitations 
of the model used to compute CSP, receptor flexibility, and extent and distribution of 
CSP assignment on the docking success. 
An additional chapter compares results obtained with QCSPScore with the results that 
the method AutoDockFilter (Stark and Powers, 2008) would have produced the same 
data set. Finally, other methods are also considered for the discussion on the advantages 
that QCSPScore method represents and the aspects that require further study. 
5.2  DrugScore  performance  on the Astex dataset:  generation 
of native-like and decoy poses 
DrugScore is one of the most reliable scoring functions for identifying (Gohlke, et al., 
2000) and generating (Velec, et al., 2005) native-like docking solutions (Wang, et al., 
2003; Ferrara, et al., 2004), with success rates of about 75%. Still, docking based on 
only DrugScore may fail due to, e.g., not considering interactions to structural waters, 
wrongly  assigned  protonation  states,  or  missing  entropy  terms.  As  a  consequence, 
docking  decoys  then  obtain  a  more  favorable  DrugScore  score EDS than  native-like 
solutions, leading to an “inverse” EDS gap. To study this inverse EDS gap one needs to 
generate  and  characterize  real  native-like  and  decoy  geometries,  which  was  the 
preliminary step performed. Since this involved re-docking a large set of protein-ligand 
complexes with DrugScore only, it served as an additional internal validation of the 
appropriateness of DrugScore for the tasks I am aiming at. 
Developing a method as the one proposed in this study requires a sufficiently large and 
varied number of protein-ligand complexes with: a) known high-quality structure and b) 
available CSP data. Typically if the X-ray structure is known (high-quality) there is no 
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means that crystallization was not possible and thus it is unlikely that a high quality 
structure  for  reference  is  available.  The  search  public  databases  of  structures  (PDB 
(Berman,  et  al.,  2000))  and  NMR  data  (BMRB  (Ulrich,  et  al.,  2008))  for  such 
complexes was unsatisfactory, since the few cases where both CSP and high-quality 
structures  were  available  were  also  successfully  re-docked  by  DrugScore  alone. 
Recently Stark and Powers, who have developed AutoDockFilter, a method in a similar 
spirit to ours, faced the same difficulty in assembling a data set and they resorted to 
“simulate” the experimental data (Stark and Powers, 2008). The group of Professor 
Schwalbe, who developed LIGDOCK (Schieborr, et al., 2005), have kindly provided 
me with experimental data for three protein-ligand complexes. With these antecedents, 
the strategy was to develop QCSPScore by first simulating CSP data for a large and 
varied data set and in a second step testing that development on the three complexes for 
which I had experimental data. 
The training dataset consisted of 70 out of the 85 complexes from the “Astex diverse 
set” (Hartshorn, et al., 2007) that contain ligands with aromatic rings (see Materials 
section). I re-docked these protein-ligand complexes using DrugScore only, in order to 
generate representative native-like solutions and geometric decoys. Geometric decoys 
are those poses which are not native-like but receive better scoring than the native-like 
ones (Graves, et al., 2005). In the terminology  of a classifier, they would be  “false 
positives”.  The  re-docking  exercise  provides  the  necessary  examples  and  counter-
examples for evaluating the candidate scoring schemes. Each docking consisted on 100 
runs, thus generating 100 protein-ligand conformations for every complex. These 100 
results  for  each  complex  are  subsequently  clustered  by  geometric  proximity  and 
classified as native-like if their RMSD to the native structure is < 2.0Å or non-native-
like otherwise. Finally, non-native-like solutions are classified as decoys if they obtain a 
better  score  than  the  native-like  ones.  This  classifications  result  in  three  groups  of 
complexes: I) complexes that generated only native-like solutions, i.e., the first ranked 
cluster corresponds to a native-like solution, II) complexes that generated only decoys, 
i.e., only non-native-like solutions, and III) complexes that generated both decoys and 
native-like solutions, i.e., the native-like solutions were not first ranked. Complexes, 
according to this classification, are collected in Table 5.1. 
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Table 5.1 Classification of cases according to the solutions generated by DrugScore-
only docking 
No decoys
1  Decoys + native-
like
2 
Only decoys
3 
1gpk  1r58  1ia1  1g9v 
1hnn  1sg0  1ig3  1gm8 
1hp0  1sj0  1jje  1jd0 
1hq2  1t40  1l2s  1mzc 
1hvy  1t46  1meh  1n2v 
1hwi  1tz8  1pmn  1oq5 
1j3j  1u1c  1r9o  1owe 
1k3u  1uml  1s3v  1tow 
1ke5  1unl  1t9b  1yvf 
1kzk  1uou  1xm6   
1lpz  1v0p  1xoq   
1lrh  1v48  1z95   
1n46  1v4s  2bm2   
1nav  1vcj     
1of1  1w2g     
1of6  1x8x     
1opk  1xoz     
1oyt  1y6b     
1p2y  1ygc     
1p62  1yqy     
1q1g  1yv3     
1q41  1ywr     
1q4g  2br1     
1r1h  2bsm     
48 of 70 (69%)  13 of 70 (19%)  9 of 70 (13%) 
1 Cases where the first ranked cluster had an average RMSD < 2.0Å to the native 
solution. 
2 Cases where the first ranked cluster had an average RMSD > 2.0Å to the native 
solution but also some clusters with RMSD < 2.0Å were generated. 
3 Cases where no-native-like solution was generated 
Independently  of  this  classification,  as  anticipated,  I  also  re-evaluated  DrugScore 
success rates for this data set. As discussed in the Theory chapter, docking is considered 
successful if the largest cluster of solutions contains at least one pose with a RMSD < 
2.0Å  to  the  crystal  native  structure.  Out  of  the  70  complexes  52  were  re-docked 
“successfully”  according  to  this  criterion,  which  represents  a  74%  success  rate,  as 
expected for DrugScore from previous studies (Wang, et al., 2003; Ferrara, et al., 2004). 
Unsuccessfully re-docked complexes were: 1r58, 1yvf, 1mzc, 1g9v, 1jd0, 1owe, 1tow, 
1n2v, 1oq5, 1r9o, 1gm8, 1s3v, 1z95, 1xoq, 1l2s, 2bm2, 1xm6, 1jje. Results and discussion    62 
     
This data set was also re-docked with Goldscore within GOLD (Jones, et al., 1997) in 
the original work where it was described (Hartshorn, et al., 2007). It is interesting to 
observe that despite fundamental differences in the nature of Goldscore and DrugScore 
scoring  functions, the  former empirical and the  latter knowledge-based  some of the 
unsuccessful  re-docking  cases  are  shared,  namely  those  affected  by  the  presence  of 
structural waters mediating protein-ligand interactions (1g9v, 1gm8, 1xm6 and 1r9o). 
5.3  Measuring  agreement  between  experimental  and  back-
calculated  CSP:  Pearson’s  vs.  Kendall’s  correlation  as 
candidates schemes for scoring according to QCSP 
Pearson’s correlation  has  been used  before (Gorczynski, et al., 2007) for measuring 
agreement  between  experimentally  observed  CSP  and  theoretically  back-calculated 
ones. Others relied on minimization of root mean squared errors for the same purpose 
(McCoy and Wyss, 2000; Cioffi, et al., 2008). Both are intuitive methods for such task. 
However,  they  both  are  inappropriate  in  those  cases  where  outliers  are  present. 
Measured  CSP  on  the  protein  side  due  to  ligand  binding  do  not  distribute 
homogeneously:  only  the  protons  very  close  to  the  perturbation,  i.e.,  those  in  the 
binding site, experience a very significant shift. In particular, given the rapid diffusion 
of the CSP effect with distance (~ r
-3 for the ring current effect), sets of observed CSP 
typically  comprise  a  large  majority  of  “unaffected”  CS  and  a  few  which  are, 
comparatively, largely affected. Thus, if all data must be included into the calculation, 
largely perturbed CS and unperturbed ones, Pearson’s correlation or sum of squared 
differences  is  inappropriate,  since  they  are  largely  dominated  by  those  large  shifts, 
whilst the non-changing CS provide structural information which is equally accurate 
and  valuable.  For  this  reason,  I  set  to  explore  and  compare  the  behaviour  a  rank-
correlation based scoring would have, in this case Kendall’s rank correlation (Kendall, 
1938). 
In order to compare Pearson’s correlation and Kendall’s correlation scoring schemes I 
performed a double analysis on the generated native-like and decoys: first an ANOVA 
analysis to assess the discriminatory power of both schemes; second an analysis of the 
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5.3.1  ANOVA analysis 
Recently,  Seifert  has  proposed  the  coefficients  
2  and  F  from  ANOVA  analysis  as 
suitable parameters for guiding scoring function development efforts (Seifert, 2006). 
These  coefficients  measure  respectively  “explained  variance”  of  the  scores  by  the 
scoring method -discriminatory power- and signal-to-noise ratio of scoring functions 
with respect to native-like and decoy geometries. Following those ideas, I analyzed both 
Pearson’s and Kendall’s correlation based scoring schemes in order to find evidence 
that would favour one scheme over the other.  
The ANOVA analysis was performed as described in the Methods chapter. 
2 and F 
values from the ANOVA analysis for Pearson and Kendall’s correlation based scoring 
schemes resulted, respectively, in 44%, 205.30 and 59%, 369.95. This results show the 
superiority of Kendall’s correlation based scheme over the Pearson’s correlation based 
one. Still, in absolute terms, both figures are good enough as to affirm, according from 
this analysis, that either scheme would  be suitable  for scoring  ligand poses. This  is 
according to the cut-offs described by Seifert, where a 
2 > 14% represents a “strong 
effect” of the scoring function for explaining the variance in scores in both groups, 
native-like and decoys. The ANOVA analysis gave support to introducing Kendall’s 
correlation  based  scoring,  but  was  inconclusive  with  respect  to  determining  its 
superiority  over  Pearson’s  correlation.  Preliminary  tests,  however,  showed  that  one 
obtains consistently better results when using Kendall’s based scoring. The next section 
is devoted to investigate the reasons explaining it. 
5.3.2  Advantages of robust correlation over non-robust for driving 
docking 
Preliminary  tests  not  shown  here  indicated  that  Kendall’s  based  correlation  scoring 
performs consistently better than Pearson’s correlation based. The little difference in 
performance showed by the ANOVA analysis between both schemes must then have a 
large influence when moving from a re-scoring exercise to a re-docking one, which I try 
to rationalize below. 
A first attempt to analyze the different impact of both scoring schemes can be done by 
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that a decoy is indeed a false positive. If CSP contribution is expected to rescue native-
like solutions that score worst than decoys in DrugScore terms, then this contribution 
must introduce itself a low number of those false positives. In Figure 5.1 I have plotted 
all DrugScore native-like and decoy poses generated against their respective Pearson’s 
and Kendall’s correlation coefficient. The plots are divided in four quadrants by dotted 
lines.  The  top  left  quadrant  comprises  ligand  geometries  which  are  native-like  and, 
accordingly,  attain  a  high  correlation.  Bottom-right  geometries  are  decoys,  which 
correctly  obtain  also  a  low  correlation.  Bottom-left,  despite  of  being  geometrically 
“correct”, obtain correlations comparable to the ones obtained by decoys, i.e. they are 
false negatives. Finally, the top-right quadrant includes false positives. Clearly, in the 
case of Pearson’s correlation the number of false positives is larger than in the case of 
Kendall’s correlation (36 vs. 4). Already in a re-scoring setting, this test is telling us that 
bad solutions are much more likely to get a good score when evaluated in terms of 
Pearson’s correlation than when evaluated in terms of Kendall’s correlation. The next 
step is to explore why it is happening. Results and discussion    65 
     
 
Figure 5.1 Pearson’s and Kendall’s correlation vs. RMSD for each ligand orientation 
considered  in the training data set. Dotted vertical  line divides  native-like and 
decoy  geometries.  Horizontal  dotted  line  divide  “high”-score  geometries  from 
“low” score ones.  Results and discussion    66 
     
If a decoy pose gets a higher Pearson’s correlation than expected, the reason is the 
presence of outliers. It is worth considering that from the total pool of observed amide 
CSP  of  a  protein-ligand  complex,  a  few  have  considerably  larger  values  than  the 
majority.  In  this  regard,  non-robust  statistics  are  strongly  influenced  by  those  large 
values. To exemplify and illustrate this situation I will study in the case of the complex 
1ygc. In Figure 5.2 I have plotted theoretical CSP for the native complex structure vs. 
the back-calculated ones corresponding to a decoy and a native-like solution generated 
by  DrugScore,  together  with  their  respective  Pearson’s  and  Kendall’s  correlation 
coefficients. 
 
Figure  5.2  Scatterplot  of  theoretical  CSP  for  the  native  conformation  and  back-
calculated CSP for one of the decoys generated by DrugScore for 1ygc (left-hand 
side) and a native-like solution (right-hand side), together with their corresponding 
Pearson’s and Kendall’s correlation coefficients. 
By observing both scatter plots in Figure 5.2 one can easily identify a substantially 
better correlation for the native-like pose than for the decoy, even though respective 
Pearson’s correlations differ only by 0.1 (0.94 vs. 0.84). Only one CSP, substantially 
larger than the others, is disproportionately influencing the correlation coefficient. On 
the contrary, Kendall’s correlation does not give a very high score to the native-like 
solution (0.49) but it is sufficiently different from the correlation in the non native-like 
case. In fact, in relative values, the difference between the score of the decoy and the 
native-like solution in Kendall’s correlation case is three times larger than in the case of 
Pearson’s  correlation  based. This  makes  Kendall’s correlation  based scoring a  more Results and discussion    67 
     
appealing scheme, particularly for these cases where a single large CSP dominates the 
whole calculation. 
To study this phenomenon in a structural context, I have mapped the CSP onto the 
protein in Figure 5.3.  
 
 
 
Figure 5.3 Comparison of a decoy (A) and a native-like solution (C) to the native structure of 1ygc (B). Amide protons of the protein are 
represented as balls, scaled according to the magnitude of their theoretical CSP generated by the presence of the ligand. Red balls represent 
negative CSP (downfields) and blue positive (upfields). The CSP pattern generated by the native-like pose in C resembles more the one 
generated by the native structure in B than the decoy in A does, even though the geometry of both decoy and native-like pose does not 
differ much. Results and discussion    69 
     
Figure 5.3A shows one of the decoys for 1ygc. The corresponding CSP it would have 
produced on the protein are depicted as balls, centred on the amide protons and scaled 
according  to  the  absolute  magnitude  of  the  CSP.  Compared  to  the  native  structure 
(Figure 5.3B), only the phenyl ring in the top is flipped, and the other two ones slightly 
tilted. With respect to the CSP pattern, two main differences between the decoy and the 
native structure are worth noting: 1) the difference in the magnitude of the CSP of Gly 
213, induced by the different tilting angles of two lower phenyl rings of the ligand and 
2) the different patterns in upfield CSP (blue balls) involving the residues in the upper 
part of the figure, caused by the different orientation of the phenyl ring at the top. A 
subjectively evaluation these two differences in the patterns suggests that the first one, a 
reduced magnitude of a single CSP, is not that critical than the second one, where some 
CSP disappear and new ones appear. However, the CSP of Gly 213 plays a greater role 
in computing Pearson’s correlation, just because of its absolute magnitude.  
Collected evidence from ANOVA analysis and the analysis of the sensitivity to outliers 
for both schemes points to Kendall’s correlation as superior scoring scheme  for the 
purposes I am aiming at. I set thus -EQCSP to be Kendall’s . 
It is interesting to note that these results emerged even in the ideal setting where only 
theoretical data has been used. It is not unreasonable to expect new sources and classes 
of outliers in a scenario where calculations are done with real experimental data. These 
new outliers will appear from imperfections of the theory and will compromise even 
more the convenience of a Pearson’s correlation based scheme. 
In what follows, I study the energy gaps between decoys and native-like solutions, both 
in EDS and EQCSP terms, in order to establish the most appropriate weighting strategy for 
mixing both contributions. 
5.4  Energy  gap  analysis  between  native-like  configurations 
and decoys 
From  the  QCSPScore  equation,  QCSP QCSP DrugScore hybrid E E E    ,  the  weight  for  the 
experimental contribution QCSP must be established. To that end I started by studying 
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and decoys (see Theory). The rationale of mixing DrugScore with CSP has been that, 
while decoys score better than native-like solutions in EDS terms, they do otherwise in 
EQCSP terms. As a consequence, an appropriate weighting of EQCSP will compensate the 
“negative EDS gap”. And thus, finding out whether a general weighting scheme can be 
applied becomes a key point of this investigation. The strategy has been to start by 
analyzing differences in EDS and EQCSP contributions between decoys and native-like 
solutions, respectively. While DrugScore values are different for each protein-ligand 
system, EQCSP values, being a correlation coefficient are constrained between -1 and +1. 
The question is double: is there a typical DrugScore energy gap between decoys and 
native-like solutions, possibly reflecting known missing terms in the scoring function 
such as vibrational entropy loss? And do native-like solutions have a typical value for 
EQCSP, sufficiently different from non-native-like ones? 
For analyzing the EDS gap between decoys and native-like solutions it is only possible to 
study the group of 13 cases (group II, Table 5.1) for which both species were generated. 
Figure 5.4 shows the distribution of energy differences between the average energy of 
the best-scored cluster in each case containing decoys and the average energy of the 
cluster with the best average RMSD in the whole run. Interestingly, 46% of the cases 
have a low energy gap (< 0.5 DrugScore units), with an average energy gap of 0.61 
units and a maximum gap of 1.31 units. Results and discussion    71 
     
 
Figure  5.4  Distribution  of  DrugScore  energy  gaps  between  decoys  and  native-like 
solutions for the 13 cases where DrugScore-only docking generated both native-
like solutions and decoys. In 46% of the cases, the energy gap is < 0.5 DrugScore 
units, with a maximum gap of 1.31 units. 
For analyzing the EQCSP gap, I used the computed CSP for HN protons described in 
section 5.2. Given that the EQCSP contribution is represented by the negative Kendall’s 
rank correlation coefficient, native-like solutions are expected to have high correlation 
values and thus, score values close to -1 whereas decoys should score zero or more. The 
analysis  presented  in  section  5.3  has  already  disproved  this  hypothesis.  Due  to  the 
sensibility  of  CSP  to  small  geometric  variations,  very  high  scores  are  almost  never 
obtained. In particular, the analysis of the complexes in the group II (both native-like 
solutions and decoys were generated) revealed an average gap of only 0.47, with large 
standard  deviations  for  both  decoys  and  native-like  solutions  of  0.22  and  0.23, 
respectively (Table 5.2). 
Table  5.2  EQCSP  scores  for  decoys  and  native-like  solutions  and  differences  for 
those cases of complexes of the Astex data set where both decoys and native-like 
solutions were generated when using DrugScore-only docking. 
PDB  -EQCSP decoy
1  -EQCSP native-like  Difference 
1ia1  0.60  0.56  -0.04 
1ig3  0.23  0.82  0.59 
1jje  0.01  0.79  0.78 
1l2s  0.17  0.72  0.55 
1meh  0.10  0.54  0.44 
1pmn  0.41  0.85  0.44 Results and discussion    72 
     
PDB  -EQCSP decoy
1  -EQCSP native-like  Difference 
1r9o  -0.07  0.85  0.92 
1s3v  0.21  0.63  0.42 
1t9b  -0.10  0.85  0.95 
1xm6  0.19  0.86  0.67 
1xoq  0.45  0.47  0.02 
1z95  0.09  0.09  0.00 
2bm2  0.54  0.90  0.36 
Average:  0.22  0.69  0.47 
Standard Deviation:  0.22  0.23  0.33 
1 EQCSP is the negative Kendall’s rank correlation coefficient between computed CSP for 
a given ligand pose and CSP reference data computed for the native state.  
 A more representative analysis can be performed by expanding this sample to those 
cases where either no decoys or no native-like solutions were generated (groups I and 
III from Table 5.1). The distributions of the -EQCSP scores for these cases are shown in 
Figure 5.5: 79% of the native-like cases score over 0.7 while only 4% of the decoys 
obtain  EQCSP  contributions  worse  than  that  figure.  This  confirms  an  intuitive 
expectation: I) native-like solutions show poorer scores than expected; II) EQCSP scoring 
is  more specific than sensitive, that is,  it  is  better at rejecting decoys than  favoring 
native-like solutions, which in line with the original goal for QCSPScore. As already 
stated,  the fact that some native-like poses show poor EQCSP scores reflects a “hard” 
scoring term character (Schulz-Gasch and Stahl, 2003), where slight changes  in the 
orientation of a ligand with respect to the native state translate into large changes of the 
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Figure 5.5 Distribution of the -EQCSP contributions for decoys and native-like poses, 
considering the subset of the Astex data set that contained ligands with aromatic 
rings. The CSP data for the bound ligand configuration was computed.  
5.5  Weighting of the EQCSP contribution 
The  analysis  of  both  the  EDS  and  EQCSP  contributions  for  decoys  and  native-like 
solutions leads us to suggest three alternative weighting factors: 
I)  As EQCSP gap, I take the difference of the median values of decoys (0.29) and 
native-like solutions (0.82), which results in EQCSP  0.6. Since the sample 
for establishing the EDS gap is much smaller, I take the maximum EDS gap 
(1.31 units) plus one standard deviation (0.45), which results in EDS 1.80. 
The  weighting  factor to  compensate  an  “inverse” EDS  gap  by  EQCSP  then 
results in QCSP = 3. 
II)  I consider different cut-offs for the EQCSP gap, in order to include 75% of the 
decoys (lowest scores; 3rd quartile: 0.47) and 75% of the native-like cases 
(best scores; 1st quartile: 0.73), which results in EQCSP  0.2. Considering 
the same EDS gap as in I), I then set the weighing factor to QCSP = 10. 
III) For the sake of completeness, I also explore an intermediate weighting factor 
of QCSP = 5. 
I note, though, that this is still a theoretical framework of development. The weighting 
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completeness  of  the  experimental  data,  the  appropriateness  of  the  model  for  back 
calculating CSP, etc. These and their effects on the weight I will evaluate and discuss in 
section 5.7 
5.6  Docking with computed CSP reference data 
 
Table 5.3 shows the percentage of docking successes for the 70 complexes from the 
Astex diverse data set, using the hybrid scoring function and considering each of the 
weighting factors proposed above. Again, CSP of HN protons computed for the native 
ligand configurations were used as reference to determine EQCSP. I considered docking 
results successful when the largest cluster of poses contains at least one solution with an 
rsmd to the native ligand pose of < 2.0Å. Compared to DrugScore-only docking (71% 
successful dockings) a large improvement in the docking accuracy is already achieved 
when QCSP = 3 is used for weighting the EQCSP contribution (87% successful dockings). 
Thus, for the additional 11 cases that can now be docked successfully, the “inverse” EDS 
gap between decoys and native-like solutions is sufficiently small so that a small EQCSP 
contributions suffices to compensate for it. All cases are recovered when QCSP = 10 is 
applied. Importantly, cases initially successfully docked with DrugScore-only did no 
suffer  deterioration.  Thus,  the  scoring  optima  coincide  for  both  the  EDS  and  EQCSP 
contributions in these cases. Finally, in the last column I have collected the number of 
cases that would have been successful under a more stringent RMSD cut-off of  1.0 Å. 
Such analysis is interesting to assess whether introducing CSP data also increases the 
native-likeness of the generated solutions. As discussed, such high-quality structures are 
a  pre-requisite  for  subsequently  performing  more  sophisticated  binding  energy 
calculations (Velec, et al., 2005; Bertini, et al., 2007). The impact of CSP in this respect 
is even higher than considering the standard success criterion. At the lowest weight 
QCSP = 3 the number of cases where solutions in the largest cluster had an RMSD  1.0 
Å to the native structure increased a 48% with  respect to the DrugScore-only case, 
which  indirectly  shows  that  the  sampling  is  more  concentrated  around  native-like 
structures. Results and discussion    75 
     
 
Table 5.3: Docking results for the 70 complexes of the Astex diverse set containing 
ligands with aromatic rings as a function of the weighting factor QCSP. 
  Successful
1  Unsuccessful, 
native-like
2 
Unsuccessful, 
no native-
like
2 
L.C.  1.0 Å
3 
No QCSP  50 (71%)  13 (19%)  7 (10%)  33 (47%) 
QCSP = 3  61 (87%)  8 (11%)  1 (2%)  49 (70%) 
QCSP = 5  65 (93%)   5 (7%)  0  58 (83%) 
QCSP = 10  70 (100%)  0  0  60 (86%) 
1A case is considered successful when the largest cluster’s average RMSD to the native 
structure is < 2.0Å. 
2For the unsuccessful cases, I also distinguish those that at least generate a native-like 
solution from those that do not. 
3Number of cases where the largest cluster’s average RMSD to the native structure is  
1.0Å. 
5.7  Docking with experimental CSP reference data 
For the above results, I used computed HN CSP from ligand-bound complexes. That 
way,  the  problem  is  simpler  than  a  real-case  scenario  where  other  factors  such  as 
conformational changes of the protein upon complex formation or other experimental 
uncertainties play also a role. Additionally, in an experimental setting, it is not always 
possible to observe and assign all HN CSP in the binding site region, which imposes an 
additional difficulty when trying to match theoretical patterns of interaction. In a sense, 
having  neglected  all  those  circumstances  contributed to  achieving  the  reported  high 
docking success rates when using “theoretical” CSP information. The purpose of this 
section is then to study the transferability of the weighting schemes developed above for 
theoretical  data  and  analyze  in  finer  detail  the  behavior  of  QCSPScore  “real-case 
scenario”, testing the assumptions made so far. 
To that end, and as announced in section 5.1, I used three protein-ligand complex for 
which there  is  experimental  CSP data available  (PDB codes: 1ecv, 1a9u and 1ydr). 
Results of standard re-docking with DrugScore are presented in Figure 5.6. 
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Figure 5.6 DrugScore results for 1ecv (A), 1a9u (B) and 1ydr (C). The largest cluster is 
represented by black dots. The dotted line divides native-like solutions from non-
native-like.  The  reference  conformation  from  the  crystal  structure  is  shown  in 
green. 
Out of these three cases, only for 1ecv standard DrugScore re-docking generated native-
like docking solutions. Additionally, in all cases DrugScore solutions are characterized 
by a tendency to maximally bury the ligand in the binding site, which is in agreement 
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and  vibrational entropy changes upon binding. Therefore, maximizing protein-ligand 
contacts improves the score. 
The results using QCSPScore, that is, introducing experimental CSP for each of the 
proposed weighting regimes, are collected in Table 5.4. 
Table 5.4 Docking results using the hybrid scoring scheme, for each of the tested 
weighting regimes 
Weight
2  LC Size
3  Rmsd
4  
5  % N. L.
6 
1ecv         
0  37  2.13  0.10  57 
3  35  1.92  -0.07  60 
5  35  3.26  0.01  50 
10  53  3.27  0.01  39 
1a9u         
0
  96  4.86  0.00  0 
3  77  4.80  0.11  0 
5  73  4.79  0.11  0 
10  45  4.99  0.19  5 
1ydr         
0  100  3.12  -0.16  0 
3  76  3.08  -0.04  18 
5  48  6.67  0.18  0 
10  51  10.11  0.24  0 
1 Results are presented for the proposed weighting factors QCSP = {3,5,10} in addition 
to DrugScore-only docking. 
2 The weighting factor QCSP. DrugScore-only docking corresponds to weight 0. 
3 Size of the largest cluster of solutions. 
4 Average RMSD of the poses of the largest cluster with respect to the native crystal 
structure. In Å. 
5 Average Kendall’s correlation coefficient of the poses in the largest cluster 
6 Percentage of native-like solutions among the whole pool of 100 generated solutions. 
The first and most striking observation is that only in one case, 1ecv with a QCSP = 3 I 
obtained  better  RMSD  average  of  the  largest  cluster  using  CSP  than  when  using 
DrugScore only. In all other cases, results were comparable to the DrugScore only case 
or worst, which is in sharp contrast with the results obtained for the simulated data, 
where  eventually  all  complexes  were  correctly  docked.  Clearly,  real  data  poses 
significantly different challenges than simulated and in what follows I will discuss the 
sources and interpretation of these discrepancies. 
A remarkable difference between theoretical and real cases is the average Kendall’s 
correlation values that native-like solutions obtain in both scenarios. Whereas in the 
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not go beyond 0.2 at the highest tested QCSP = 10. Since the theoretical analysis proved 
that scanning up to that value of  QCSP = 10 is enough for the CSP contribution to 
effectively drive the docking, an inappropriate weighting scheme can be ruled out as the 
cause  for  lack  of  success.  What  remains  is:  a)  inaccuracies  in  the  model  for  back-
calculating CSP and b) the influence of incomplete/asymmetrically distributed set of 
observed CSP, since in the theoretical case all HN in the binding site were considered 
but these cannot be always observed/assigned in an experimental scenario. 
A very illustrative example of the influence of incomplete/asymmetrical assignments is 
the case of 1ydr. At QCSP = 10, 1ydr resulted in solutions with an RMSD to the native 
structure >10Å, considerably worst than what DrugScore only, ~ 3 Å due to a change in 
the orientation of the quinoline ring (Figure 5.6 C). In Figure 5.7 the native structure of 
1ydr is represented together with one of the wrong solutions at 10 Å RMSD and the 
assigned CSP. The aforementioned asymmetry in the assignment of CSP is evident from 
the  picture.  The  wrong  solution  corresponds  to  the  next  most  buried  one  after  the 
original  decoy  and  the  native  structure,  i.e.  the  following  in  decreasing  order  of 
DrugScore terms, but the best explored in terms of EQCSP. Indeed, the wrong ligand 
orientation, given the lack of restrains for example from Asn-171 or Glu-170 reproduces 
the CSP on the top right of the picture without interfering with other CSPs. Results and discussion    79 
     
 
Figure  5.7  Binding  site  area  of  the  native  structure  of  1ydr  complex  (ligand 
conformation green) and a wrong solution generated by QCSPScore at QCSP = 10 
(ligand conformation in yellow). Red spheres represent negative CSP and blue 
spheres positive CSP, cantered at HN and scaled according to their absolute value. 
Green  spheres  are  observed  CS  that  do  not  change  upon  ligand  binding.  The 
experimental  data  distributes  asymmetrically:  most  of  the  observed  CSP 
correspond to the upper part of the figure and in the lower part, residues for which 
no experimental data was available are labelled. 
With respect to the inaccuracies of the  model, the effect on docking  is apparent by 
means of an increase of indetermination. I.e., the restraints that CSP introduce, given 
that  the  errors  in  the  calculations  of  specific  HN  are  bigger  than  their  relative 
differences,  allow  for  an  exchange  of  observations:  an  electrostatic  effect  can  be 
compensated  by  a  ring-current  effect  and  vice  versa.  An  example  is  what  one  can 
observe  in  the  case  of  1a9u.  Assignments  here  are  more  complete  than  for  the 
aforementioned  1ydr  case.  However,  four  aromatic  rings  give  enough 
chance/indetermination for the molecule to accommodate better alternative orientations 
than the native one. Along this line, I considered alternatively to the full model for back 
calculating CSP, focus only on the ring current effects. Ring current effects are known 
to be the largest in proportion and more importantly define a specific pattern (McCoy 
and  Wyss, 2000). The  hypothesis was that the electrostatic contribution, the way  is 
implemented here and considering how far apart from each other HNs are in a protein is 
more a source of noise than valuable information. For example, a very tight protein-
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strong CSP. This strong CSP can be equal in magnitude to the one produced by an 
aromatic ring, and if the aromatic ring is not deeply bound in the protein and/or no 
sufficient CSP around it have been observed, ring-current and electrostatic effects can 
be interchanged. It is known that including electrostatics improves the global correlation 
between experimental and  back-calculated CSP (Osapay  and Case, 1991). However, 
this limited global improvement does not negate the fact that a model consisting of the 
effect of ring-currents only accounts for the largest part of that correlation. In what 
follows, I analyze the effect of neglecting electrostatics. 
5.7.1  Improved accuracy by neglecting electrostatics 
Table 5.5 summarizes the docking results with the hybrid scoring function, but now 
considering only ring-current effects. The results confirm the hypothesis that targeting 
only  “well-defined”  interaction  patterns  such  as  the  ring-current  effects,  despite 
theoretically losing accuracy in the total CSP prediction, is at this time a better strategy. 
Table 5.5: Summary of docking results for three complexes where experimental 
CSP reference data was available 
Weight
2  LC Size
3  Rmsd
4  
5  % N. L.
6 
1ecv         
0  37  2.13  0.10  57 
3  60  1.84  0.13  70 
5  37  1.80  0.14  78 
10  51  1.36  0.34  87 
1a9u         
0
  96  4.86  0.00  0 
3  76  4.80  0.06  1 
5  59  4.80  0.07  1 
10  42  1.13  0.25  42 
1ydr         
0  100  3.12  -0.16  0 
3  72  0.75  0.07  72 
5  61  0.81  0.07  61 
10  56  10.10  0.24  0 
1 Results are presented for the proposed weighting factors QCSP = {3,5,10} in addition 
to DrugScore-only docking. 
2 The weighting factor QCSP. DrugScore-only docking corresponds to weight 0. 
3 Size of the largest cluster of solutions. 
4 Average RMSD of the poses of the largest cluster with respect to the native crystal 
structure. In Å. 
5 Average Kendall’s correlation coefficient of the poses in the largest cluster 
6 Percentage of native-like solutions among the whole pool of 100 generated solutions. Results and discussion    81 
     
Now  in  all  three  cases  native-like  solutions  were  generated  and  in  some  of  the 
weighting schemes these accounted for the largest cluster. Docking results with and 
without using CSP and the effects of them are also depicted in Figure 5.8. 
 
Figure 5.8 Comparison of docking solutions (magenta) with the crystal structure (cyan). 
In  the  first  column  (A,  D,  G),  results  using  only  DrugScore  for  scoring  are 
presented;  the  second  and  third  columns  (B,  C,  E,  F,  H,  I)  display  the  best 
solutions  obtained  with  QCSP-steered  docking.  Results  for  complex  1ecv  are 
given in panels A, B, C; for 1a9u in panels D, E, F; for 1ydr in panels G, H, I. In 
the second column experimental CSP are mapped to the protein whereas in the 
third  column  calculated  CSP  corresponding  to the  docked  pose  using  the  ring 
currents-only  model  are  displayed.  Blue  balls  represent  upfield  shifts  (positive 
CSP), red ones downfield shifts (negative CSP), and green balls are used to mark 
CSP that have been assigned but do not experience any perturbation. The size of 
the blue and red balls is proportional to the magnitude of the CSP.  Results and discussion    82 
     
With respect to the question whether an optimal weight exists, one can recognize that 
the  docking  experiments  with  computed  CSP  reference  data  already  suggested  that 
QCSP = 10 is an appropriate weighting factor in general. This scheme was appropriate 
also for 1ecv and 1a9u, which largest clusters had respectively 1.36Å and 1.13Å RMSD 
on average to the native structure. In contrast, for 1ydr, successful docking with RMSD 
~ 0.8Å required lower  QCSP values of 3 or 5. The requirement to use lower  QCSP 
values  points  to  the  problem  of  over-emphasizing  the  influence  of  imperfect 
experimental CSP reference data and/or neglecting shortcomings in the computational 
model  used  for  back-calculating  CSP  from  a  given  ligand  pose.  I  thus  set  out  to 
investigate in more detail factors that influence the performance of the hybrid scoring 
scheme in the case of experimental CSP reference data. I identify as the most important 
determinants hydrogen bond formation, extent and distribution of the CSP assignment, 
and flexibility of the target. The latter also includes structural differences of the NMR 
and X-ray determined protein structures. 
5.7.2  The hydrogen-bond effect 
In both the 1a9u and 1ydr cases, the ligand forms a hydrogen bond to an HN proton in 
the protein for which experimental CSP were available. The effect of a hydrogen bond 
formation cannot be modeled accurately with current empirical methods (Osapay and 
Case,  1991;  Wishart  and  Case,  2001;  Parker,  et  al.,  2006;  Moon  and  Case,  2007). 
Accordingly,  following  preliminary  tests,  I  decided  to  omit  this  effect  when  back-
calculating  CSP.  In  the  case  of  1a9u,  the  presence  of  the  hydrogen  bond  formed 
between the pyridine N and HN of Met-109 did not deteriorate the final docking result 
(Table 5.5). This is because back-calculating the CSP of HN of Met-109 is successful 
(Figure 5.8E, F) even with the ring current-only model, if the pyridine ring of the ligand 
adopts a slightly tilted and displaced conformation compared to the native structure. A 
similar observation was already described by McCoy and  Wyss (McCoy and  Wyss, 
2002) who pointed out that the typical downfield shift of a proton in a hydrogen bond 
can also be generated by a properly oriented aromatic ring in the proton’s vicinity. I 
note,  however, that  such  a  fortuitous  effect cannot occur  in  the  case  of  a  narrower 
crevice, which does not allow ring tilting and displacement. That situation compromises 
the docking accuracy, as demonstrated for 1ydr. Here, the ligand is forming a hydrogen 
bond  with  the  HN  proton  of  Val-123  (Figure  5.8G).  At the  same  time  it  is  tightly Results and discussion    83 
     
constrained in the binding pocket. Thus, no evasive movements of the quinoline ring are 
possible  allowing  for  a  compensation  of  the  missing  hydrogen  bond  term  when 
computing the CSP. As a result, a  low EQCSP score is obtained even  for native-like 
solutions. Following the idea that no CSP contribution at all must be better than a wrong 
contribution, I repeated the docking without considering HN of Val-123. Results for 
1a9u and 1ydr without their respective HN known to be involved in a hydrogen bond 
are  collected  in  Table  5.6.  With  an  average  EQCSP  score  improving  modestly  but 
significantly from -0.07 to -0.12 for native-like solutions, a successful docking was now 
achieved with QCSP = 10. Thus, all three complexes with experimental CSP reference 
data were successfully docked using a uniform weighting factor QCSP = 10. 
Table  5.6  Docking  results  using  CSP  and  neglecting  HN  involved  in  hydrogen 
bonds. 
Weight
2  LC Size
3  Rmsd
4  
5  % N. L.
6 
1a9u – no Hbond         
0
  96  4.86  0.00  0 
3  81  4.83  0.04  0 
5  70  4.82  0.04  1 
10  67  1.06  0.22  67 
1ydr – no Hbond         
0  100  3.12  -0.16  0 
3  80  0.76  0.11  80 
5  98  0.81  0.12  98 
10  54  0.84  0.12  54 
1 Results are presented for the proposed weighting factors QCSP = {3,5,10} in addition 
to DrugScore-only docking. 
2 The weighting factor QCSP. DrugScore-only docking corresponds to weight 0. 
3 Size of the largest cluster of solutions. 
4 Average RMSD of the poses of the largest cluster with respect to the native crystal 
structure. In Å. 
5 Average Kendall’s correlation coefficient of the poses in the largest cluster. 
6 Percentage of native-like solutions among the whole pool of 100 generated solutions 
The limitation in describing CSP due to hydrogen bond formation is well-known, and 
more work is needed on the theoretical side to improve on this. In the meantime, one 
possibility to circumvent this  limitation  is omitting CSP  induced  by  hydrogen  bond 
formation from the hybrid scoring scheme. These CSP can be identified by visually 
inspecting the experimental CSP pattern. Typically, a hydrogen bond is characterized by 
a large downfield perturbation, which can be of a similar magnitude as the one due to a 
nearby aromatic ring. However, a hydrogen bond-induced CSP usually appears isolated Results and discussion    84 
     
and does not show the typical pattern of CSP on neighboring atoms that an aromatic 
ring would induce. 
5.7.3  Influence  of  the  extent  and  spatial  distribution  of  CSP 
assignment 
The  extent  of  CSP  assignment  of  HN  protons  in  the  binding  site  area  of  the  three 
complexes is 33% and 37% for 1ecv and 1ydr, respectively, and 75% for 1a9u. Despite 
the  comparable  extent  of  HN  CSP  assignments,  the  highest EQCSP  values  found  for 
native-like solutions of the first two complexes differ considerably (1ecv: -0.34; 1ydr: 
-0.11, omitting the HN involved in a hydrogen bond). This difference can be explained 
by the spatial distribution of the CSP assignment. In the case of 1ecv, the CSP distribute 
uniformly around the binding site and so capture the traits of the ring-current pattern 
(Figure 5.8B). On the contrary, for 1ydr, the assignment excludes a large part of the 
adenosine-binding  pocket  surface  (Langer,  et  al.,  2004),  which  leads  to  increased 
minimal EQCSP scores as the ring-current pattern lacks key reference points in space 
(Figure 5.8H). Thus, in the case of sparse experimental CSP data, it is the distribution of 
the CSP rather than the amount of data per se that determines the success of QCSP-
steered docking. 
5.7.4  Influence of the target flexibility 
In all three studied cases the proteins undergo re-arrangements upon ligand binding, 
with RMSD of the binding sites between bound and unbound conformations ranging 
from 0.73Å in the case of 1ecv and 1.0Å in the case of 1a9u to 2.1Å in the case of 1ydr. 
Protein re-arrangements are challenging for properly back-calculating CSP in a rigid-
protein docking scheme because aromatic ring movements in the protein can produce 
CSP  as  large  as  those  induced  by  a  ligand.  Rearrangements  of  solvent  molecules 
contribute  to  CSP,  too.  At  present,  QCSPScore  assumes  that  most  of  the  observed 
effects  can  be  directly  attributed  to the  ligand  as  a  source  and  that  this  proportion 
suffices to orient the ligand in the native-like position. If the ligand is the major source 
of  CSP,  EQCSP  scores  should  be  approximately  -1  for  native-like  poses,  perfect 
correlation. In turn, an increase of the minimal EQCSP score is expected with increasing 
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here). Too large protein movements will thus render the model for back-calculating CSP 
insufficient. Nonetheless, even movements up to 2.1Å RMSD are still tolerated in the 
case of 1ydr. In general, I note that target flexibility is not a limitation for the hybrid 
scoring scheme described here. I believe that using CSP information can be very helpful 
in a fully-flexible protein-ligand docking scenario, because protein refinement against 
such data has been shown to improve structural quality (Clore and Gronenborn, 1998), 
and one ought to expect the same for a complex structure. 
It is also interesting to note that not only protein movements upon ligand binding can 
deteriorate the accuracy of CSP computation but also structural differences of protein 
structures originating from different experimental sources or conditions. This point is 
illustrated by the HN proton of Lys-53 of 1a9u. The HN proton experiences a downfield 
shift in experiment, whereas the model implemented in QCSPScore predicts an upfield 
shift for the native-like solution. The latter corresponds to a position of the proton in or 
close to the plane of the aromatic ring. In the native structure, it can be seen that the 
proton is almost co-planar to the ring, too. Accordingly, the computed CSP for this 
structure  also  shows  an  upfield  shift.  The  experimental  downfield  shift  can  be 
reproduced properly if an alternative crystal structure of the same complex (PDB id: 
2ewa) is used, which differs slightly in the mutual orientation of the ring and the HN of 
Lys-53 (Figure 5.9). Again, as in the case of the hydrogen bonds, local disagreements 
between experimental and computed CSP can be compensated by a complete and/or 
well-distributed  CSP  assignment.  It  is  the  global  CSP  pattern  then  that  still  allows 
finding native-like solutions (Figure 5.8E vs. Figure 5.8F). 
 Results and discussion    86 
     
 
Figure 5.9 Superimposition of p38 complexes  2ewa (model 1) (magenta) and 1a9u 
(cyan). The angle between the ring plane and a vector from the ring center to the 
HN of Lys-53 differs by 12º (2ewa: 31º; 1a9u: 23º). This difference is sufficient to 
predict a downfield shift for 2ewa (CSP: -0.18) and an upfield shift for 1a9u (CSP: 
0.07) using the empirical model implemented in QCSPScore. 
5.8  Comparison to related methods 
In the last years, there has been a growing interest in developing methods capable of 
harnessing  structural  information  contained  in  protein  CSP  upon  ligand  binding  for 
solving protein-ligand complexes. The methods published so far differ from one another 
mainly in two aspects: first whether they use CSP quantitatively or quantitatively and, 
second, whether CSP are employed for pre-/post-filtering (or refinement) or to drive 
docking. A more thorough review on these methods can be found in the Introduction 
chapter of this work. Here, a summary of the methods, attending to the aforementioned 
classification is presented in Figure 5.10.  Results and discussion    87 
     
 
Figure 5.10 Classification of methods that use CSP for protein-ligand docking. 
A  “qualitative” use of CSP considers exclusively  information regarding presence or 
absence of perturbation in a residue’s CS. In “semi-quantitative” methods CSP are only 
considered in absolute magnitude, thus neglecting the sign of the perturbation and not 
making a difference upfield or downfield effects. QCSPScore, the method described in 
this work, belongs to the “quantitative” category. In what follows I compare directly the 
semi-quantitative use of CSP vs. the quantitative use done in this work and CSP-driven 
approaches vs. post-filtering strategies. 
5.8.1  Semi-quantitative vs. quantitative scoring 
Both AutoDockFilter and LIGDOCK share common principles. They rely on the idea of 
ambiguous restraints which can be defined from the observed CSP. In AutoDockFilter it 
is assumed that the intensity of observed protein CSP upon ligand binding are linearly 
distant-dependent to any ligand atom. Thus, the authors have defined a violation energy 
ENMR as  

 
n
i
Dist NMR k E
1
2 ) ( , where Dist penalizes ligand poses as long as any of the 
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performance of such a scoring  method on the same data set used  in the theoretical 
development of QCSPScore. For that, I considered the subset of the Astex data set that 
generated both native-like and non-native-like solutions using standard DrugScore, as 
done  in  the  initial  scoring  function  assessment  (see  section  5.2,  above).  As  the 
developers  of  AutoDockFilter  did,  I  also  simulated  CSP  for  these  complexes 
considering  a  simple  linear  relationship  between  residues  in  the  binding  site  of  the 
protein and the nearest ligand atom. Then, I calculated the corresponding ENMR for each 
pose in a post-filtering fashion. I considered a very relaxed criterion and accepted as 
“successful” those cases in which the native-like solutions obtained the lowest ENMR, 
independently if this lowest score was also shared by a non-native solution. 
Simplifying the relationship of observed CSP to a linear distance dependency to the 
source  of  the  perturbation  is  a  very  crude  approximation.  On  the  one  hand  it 
circumvents the necessity of expensive calculations for predicting CSP, but on the other 
hand, that simplification can only provide information about the location of the binding 
site and anchor the ligand to it. Such approaches have a deep impact in protein-protein 
docking where possible relative orientations of the interacting partners are considerably 
larger than in the protein-ligand case (van Dijk, et al., 2005a). However, in the protein-
ligand docking case, the real problem comes when the ligand is properly placed in the 
binding  site  but  two  or  more  (symmetrically  or  not)  alternative  conformations  are 
plausible, since CSP information used in that fashion does not provide additional clues. 
Schieborr et al. faced that problem when trying to re-dock 1a9u (Schieborr, et al., 2005). 
I have seen the very same effect in the cases analyzed here using AutoDockFilter as 
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Figure 5.11 A decoy (left) and a native-like solution (right) for 1l2s complex. Both 
conformations  are  indistinguishable  to  AutoDockFilter,  whereas  Kendall’s 
correlation  coefficient  for  decoy  and  native-like  solutions  are  0.13  and  0.70 
respectively. 
What happened to 1l2s complex is a clear example of the limitations of AutoDockFilter. 
Whereas  for  this  scoring  function  both  solutions  shown  in  Figure  5.11  (decoy  and 
native-like) are indistinguishable. As a matter of fact, the decoy gets a slightly better 
solution than the native-like solution. They both generate clearly different CSP patterns, 
properly  captured  by  the  Kendall’s  correlation  based  scheme  implemented  in 
QCSPScore ( = 0.13 for the decoy and  = 0.70 for the native-like pose). 
In summary, despite the limitations discussed in the previous section, I believe these 
results  show  that  quantitative  CSP  is  a  remarkable  advantage  towards  successful 
docking  results,  compared  to  qualitative  or  semi-quantitative  use.  In  fact,  if  semi-
quantitative  data  is  used  in  a  pre-filtering  step  in  order  to  narrow  the  binding  site 
definition, all structural data contained in it is already exploited. 
5.8.2  CSP-driven vs. post-filtering approaches 
The first approaches in which quantitative CSP data was used consisted of post-filtering 
methodologies (McCoy and Wyss, 2000). Arguably, such approaches are convenient as 
long as one is confident that the generator of conformations is going to sample and 
produce native-like solutions for the starting pool. In the case of rigid-ligand docking it 
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ligand docking is not a common practice anymore, unless one is sure of the bioactive 
conformation of the ligand. Running a docking program in a standard-fashion, the most 
likely scenario does not ensure that pre-condition: for the data set analyzed here 9 out of 
70  cases  (13%),  no  native-like  solution  was  generated  at  all.  Similarly,  Stark  and 
Powers reported that blind AutoDock calculations on 19 complexes resulted in 5 cases 
not generating any native-like poses (120 dockings runs for each complex) (Stark and 
Powers, 2008). 
But incorporating CSP at docking time imposes the challenge of defining how to weight 
the experimental  information. Schieborr et al. (Schieborr, et al., 2005) resorted to a 
standard  NMR-like  methodology,  switching  on  and  off  the  contribution  along  the 
simulations, followed by a “selection plot” for scoring poses. The selection plot was 
necessary for example to evaluate 1ydr poses, where no single criterion, van der Waals 
interactions or matching experimental data, sufficed. Despite their success, the method 
incurs in very low efficiency. Cioffi et al. (Cioffi, et al., 2008) seem to acknowledge the 
aforementioned problems of post-filtering and resort to non-standard use of the docking 
program: first, only vdW contributions of the scoring function are left on; second, so 
generated poses are not re-scored but optimized in CSP terms. This also reflects that 
CSP alone do not suffice to orient protein and ligand starting from a given random 
orientation. QCSPScore is more efficient in since the whole simulation is done in a 
single step. 
5.8.3  QCSPScore vs. other quantitative approaches 
Probably, the most sophisticated method among the so far cited, and also more similar 
to QCSPScore, is the one by Cioffi et al., being a fundamental difference the functional 
form of the scoring function. As long as difficulties remain to model more correctly 
CSP (e.g. with respect to hydrogen formation) a Kendall’s correlation based scheme, is 
preferable, as I have shown  here. Unfortunately, the authors did  not report cases  in 
which  they  re-docked  protein-ligand  complexes  and  hydrogen-bond  effects  were 
present, to properly evaluate the impact of such effect. Additionally, Cioffi et al. used a 
model for back-calculating CSP which included ring-current effects, electrostatic and 
other magnetic effects. I have shown that the ring-currents-only model works better in 
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difficult to evaluate differences also in this respect, since they have reported results only 
for one case.  Additionally,  it would  have  been  also  interesting to see whether their 
method really outperformed standard docking, without any CSP information, as is the 
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6  Summary, conclusions and outlook 
In this work, I have presented the development of QCSPScore, a new computational 
method  that  exploits  quantitatively  observed  chemical  shifts  perturbations  of  amide 
protons  on the  protein  side  to  steer  a  protein-ligand  docking  engine.  QCSPScore  is 
implemented within AutoDock, which permits a convenient straightforward use. 
QCSPScore has been conceived  as a  hybrid scoring  function that combines  linearly 
DrugScore  potentials  with  a  measurement  of  the  agreement  between  experimentally 
observed and back-calculated QCSP for a given docking pose. The back-calculation of 
CSP is done using an empirical model, in order to keep the whole approach efficient. 
The  core  of  the  work  has  therefore  been  devoted  to  study:  a)  how  that  agreement 
between experimental and back-calculated QCSP can be measured and b) determine 
how to relatively weight QCSP contribution with respect to DrugScore (Gohlke, et al., 
2000). 
Since  large  collections  of  experimental  data  were  not  available  for  developing  and 
testing  purposes,  I  have  followed  a  two-step  strategy.  First,  I  considered  a 
comprehensive data set of 70 protein-ligand complexes from the Astex diverse data set 
(Hartshorn, et al., 2007) for which I computed QCSP data for reference. Second, results 
obtained  in  this  step  were  translated  and  re-evaluated  using  three  protein-ligand 
complexes for which experimental QCSP data was available. 
In the theoretical development part, complexes were re-docked using DrugScore-only as 
scoring function, which produces correct docking results in 71% of the cases (section 
5.2). I used the structures of those correct cases and the incorrect ones (decoys) for 
establishing an appropriate functional form of the QCSP contribution. Kendall’s rank 
correlation coefficient proved to be appropriate (section 5.3). Using the rank correlation, 
it is not necessary to account for the degree of protein saturation by a bound ligand, 
which may vary from complex to complex and influence the magnitude of CSP. In 
addition, the rank correlation is a robust statistic measure, which compares favorably to 
scoring  schemes  based on  minimizing squared  deviations  between  experimental and 
computed  CSP.  I  have  ascertained  that  these  latter  scoring  schemes  show  a  high 
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To establishing the weight of the QCSP contribution  for  linearly  combining  it with 
DrugScore I analyzed again DrugScore results to assess energy gaps between decoys 
and  native-like  docking  solutions  (section  5.4).  For  the  data  set  under  study,  the 
maximum  energy  gap  in  DrugScore  terms  was  rather  low,  1.31  DrugScore  units. 
Kendall’s rank correlation values for decoys spread around 0.29 and around 0.82 for 
native-like solutions, which suggested a weight scan between 3 and 10 (section 5.5). I 
note that in these ideal cases no inaccuracies occur upon back-calculating the CSP and 
all amide protons in the binding site have a CSP value assigned, which permits isolating 
the  theoretical  influence  of  the  CSP  contribution  on  the  docking  outcome.  At  the 
smallest  weighting  factor  tested  (QCSP  =  3)  a  docking  success  rate  of  87%  was 
achieved,  already  16%  higher  than  DrugScore-only  scoring.  This  rate  improved  to 
100% at the largest weighting factor tested (QCSP = 10). Additionally, results generated 
with  QCSPScore  have  a  higher  native-likeness  than  the  cases  of  DrugScore-only 
docking. This  is also corroborated using as a more stringent criterion of success an 
RMSD to the native structure of  1.0 Å: 47% of the DrugScore-only cases would have 
been successful vs. 86% of the cases driven by QCSP at QCSP = 10 (section 5.6). In 
total, this part of the study revealed that, despite the QCSP contribution being a “hard” 
scoring term, global optimization performs satisfactorily on the combined EDS/EQCSP 
docking  energy  landscape.  In  particular,  it  increases  the  sampling  of  native-like 
conformations. 
Applying the hybrid scoring scheme with a weighting factor of 10 to the three cases for 
which experimental CSP reference data was available, resulted in successful docking if 
HN involved in hydrogen bonds with the ligand were discarded from the data pool, 
(section  5.7).  This  is  a  significant  improvement  with  respect  to  DrugScore-only 
docking,  which  was  unsuccessful  in  all  three  cases.  In  addition,  only  in  the  hybrid 
docking scheme, native-like solutions were generated for complexes 1a9u and 1ydr. 
This justifies the importance of including the experimental information at docking time, 
and not just as a pre-filter or a post-filter as has been typically done until now. 
Assessing QCSPScore with real experimental data gave the opportunity to gain some 
insight in possible limitations of the approach and how to overcome them. To start with, 
HN CSP involved in hydrogen bonds, when neglected, resulted in better performance of 
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QCSPScore for back-calculating CSP does not explicitly model this effect. However, an 
a priori surprising result was that neglecting also the electrostatic contribution included 
in  the  model  was  necessary  to  obtain  successful  results.  Since  HN  CSP  in  an 
experimental setting might distribute sparsely and asymmetrically, the appearance of 
clear patterns marking the appearance of the ligand in the binding site is hindered. For 
this  reason,  it  can  be  rationalized  that  using  a  ring-current-only  model  for  back-
calculating produced better results. Ring-current effects, when present, are the  most 
significant  components  of  the  total  observed  QCSP.  In  addition,  they  produce  a 
characteristic pattern of magnetic perturbation in their vicinity for which they can be 
used for effectively orienting ligands in their binding sites. When analyzing additional 
factors that influence the docking success, it was encouraging to see that binding site 
movements of up to 2 Å did not deteriorate the docking success when considering CSP 
information. Furthermore, an extent of CSP assignments of HN protons in the binding 
site region below 40% can still be tolerated, if the CSP are rather uniformly distributed. 
The limited experimental data set used in the development of QCSPScore, despite the 
successful  results,  does  not  permit  making  a  definitive  assessment  of QCSPScore’s 
merits.  However,  it  permitted  discovering  some  limitations,  from  a  theoretical  and 
experimental point of view, that need being addressed in the future in order to refine and 
expand its applicability. 
The low accuracy in the prediction of protein HN only has a limited impact on the 
success of the approach, compared to incomplete and  irregular patterns of HN CSP 
assignments.  However,  dealing  with  the  specific  case  of  hydrogen-bond  formation, 
better understanding and  modelling electrostatic effects on CSP would  be desirable. 
Likewise, an extension to account for protein flexibility is needed. With respect to the 
problem of HN involved in hydrogen-bonds with the ligand, Moon and Case (Moon and 
Case,  2007)  recently  proposed  an  extended  empirical  model.  It  remains  to  be 
investigated how  much the efficiency  in the calculation  is compromised by such an 
alternative. The same is true for more sophisticated treatments of the electrostatics. So-
called Generalized-Born models have become a popular alternative to more demanding 
explicit solvent models in recent years. The question is whether any of such models 
could  be  efficiently  implemented  into  QCSPScore,  and  if  the  gain  in  accuracy  will 
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back-calculating  CSP,  in  this  case  on  the  ligand  site,  have  been  recently  reported.  
NMRScore(Wang, et al., 2007) uses quantum-mechanics for this task, which is useful in 
a structural refinement effort, but not in a medium-throughput docking campaign. 
Relying on ring-currents effects only effectively limits the number of small-molecules 
that can be studied. Yet, more than 95% of the compounds in the MDL Drug Data 
Report  database  (http://symyx.com)  contain  an  aromatic  ring  and  would  thus  be 
amenable. Finally, flexibility of the protein has not been considered. However, this is 
not a limitation of QCSPScore itself, but from the underlying docking engine. 
From an experimental point of view, relying on CSP permits studying complexes for 
which NOE cannot be seen, however observing and assigning CSP is still a demanding 
task. For this reason, approaches like QCSPScore will benefit from future developments 
in  high-throughput  assignment  of  proton  chemical  shifts  and  peak  tracking 
methodologies (Fukui and Chen, 2007). 
Almost ten years ago McCoy and Wyss pioneered the use of QCSP for protein-ligand 
complex elucidation. They wrote: “We anticipate that ligand-induced chemical shifts 
perturbations  can  be  used  as  restraints  in  structure  calculations  and  can  be  energy 
minimized  with  NOEs,  van  der  Waals  and  electrostatics  to  give  more  accurate 
protein/ligand structures” (McCoy and Wyss, 2000). Since then, increasing attention has 
been paid to ligand induced CSP. A very recent work by Cioffi et al. (Cioffi, et al., 
2008) describes how QCSP can be used for optimizing protein-ligand geometries, but, 
to the best of my knowledge, the present study is the first work in which QCSP are 
incorporated into a docking scoring function for effectively driving the simulation from 
the beginning. The relevance of the direction taken in this work has been already stated. 
First, simulations where CSP were used only qualitatively or semi-quantitatively do not 
effectively exploit the experimental data to orient the ligand in the binding site; rather, 
they only  anchor  it to that area. Second, there  is a risk  for quantitative approaches 
following a post-filtering strategy to work on a pool of solutions where a native-like 
solution is not present. 
I believe that the approaches like QCSPScore can have a relevant impact when dealing 
with challenging protein-ligand complexes, which nowadays coincide to represent 
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based drug-design (Congreve, et al., 2008), where small fragments are known to be a 
challenge for classical scoring functions (Hubbard, et al., 2007; Chen and Shoichet, 
2009), and protein-protein interfaces (Arkin and Wells, 2004), which typically present 
rather flat binding sites, difficult to address for current docking programs (Gonzalez-
Ruiz and Gohlke, 2006). Zusammenfassung    97 
     
7  Zusammenfassung 
Das Docken von Liganden an Proteine ist ein in der Pharmaforschung routinemäßig 
angewendetes rechnerisches Verfahren. Eine beträchtliche Anzahl publizierter Studien 
zeigt  den  erfolgreichen  Einsatz  von  Docking  beim  virtuellen  Screening  nach 
Wirkstoffkandidaten (Kitchen, et al., 2004; Cavasotto and Singh, 2008). Auch bei der 
Optimierung  potentieller  Wirkstoffe  hat  sich  der  Einsatz  von  Dockingverfahren 
bewährt. Als ein bekanntes erfolgreiches Beispiel ist der inzwischen kommerzialisierte 
Wirkstoff Imatinib (Gleevec) zu nennen (Capdeville, et al., 2002). Trotzdem besteht 
auch weiterhin Bedarf und die Notwendigkeit, Dockingverfahren weiter zu verbessern. 
Das Docking erfordert einerseits die Vorhersage der Konfiguration oder Geometrie des 
Protein-Ligand-Komplexes, andererseits die akkurate Bewertung oder Abschätzung der 
Wechselwirkungsenergie  zwischen  den  Bindungspartnern,  das  so  genannte  Scoring.  
Was  die  erste  Anforderung  betrifft,  so  sind  Erfolgsraten  von  bis  zu  80%  berichtet 
worden (Warren, et al., 2006). Für die zweite,  schwierigere  Anforderung  liegen die 
Erfolgsraten  bei  der  Unterscheidung  einer  nativen  von  einer  nicht-nativen 
Komplexstruktur nur zwischen 10 und 70%. Bei der Reihung einer Serie von Liganden 
gemäß ihrer Wechselwirkungsenergie ist die Erfolgsrate sogar noch geringer (Warren, 
et al., 2006). Aufgrund dieser Tatsachen wird allgemein davon ausgegangen, dass das 
Problem der Geometrievorhersage weitestgehend gelöst sei, das Problem der Bewertung 
dagegen  nicht.  Velec  und  Kollegen  haben  kürzlich  gezeigt,  dass  gute 
Geometrievorhersagen Voraussetzung für die Verbesserung von Bewertungsfunktionen 
sind (Velec, et al., 2005). 
Eine Tendenz bei der Verbesserung von Bewertungsfunktionen ist die Anpassung der 
Funktion  an  ein  bestimmtes  System,  d.h.  die  Entwicklung  so  genannter 
maßgeschneiderter  Bewertungsfunktionen.  Dabei  werden  verfügbare  Daten  für  eine 
Reihe  bereits  bekannter  Liganden  genutzt  (Fradera  and  Mestres,  2004;  Jansen  and 
Martin, 2004; Radestock, et al., 2005). Alternativ können auch experimentelle Daten zur 
Verbesserung des Dockings benutzt werden, die im Rahmen der Untersuchung eines 
bestimmten Systems neu erzeugt wurden (van Dijk, et al., 2005a). Das Kombinieren 
theoretischer  Dockingmethoden  mit  neu  erzeugten  experimentellen  Daten  hat  die 
Untersuchung biologischer Systeme ermöglicht, die bislang als zu schwierig für eine Zusammenfassung    98 
     
Untersuchung  mit  Dockingverfahren  galten.  Bemerkenswerterweise  haben  diese 
Ansätze  der  Erforschung  und  Entwicklung  von  Protein-Protein-Dockingmethoden 
neuen Auftrieb gegeben (van Dijk, et al., 2005a). Aber auch im Bereich des Protein-
Ligand-Dockings werden solche Methoden  angewendet,  insbesondere  in Verbindung 
mit Kernmagnetresonanz (NMR)-spektroskopischen Daten (Carlomagno, 2005; Powers, 
2007). 
NMR-spektroskopischen Untersuchungen liefern Informationen über die Struktur eines 
biomolekularen  Komplexes.  Chemischen  Verschiebungen  (CS)  kommt  dabei  eine 
Schlüsselrolle  bei  der  Zuweisung  von  NMR-Spektren  zu.  Für  die  eigentliche 
Strukturaufklärung wurden sie bislang aber als weniger brauchbar angesehen (Szilagyi, 
1995), da ihre Interpretation hinsichtlich der Struktur schwierig ist. Seit einigen Jahren 
finden CS aber immer mehr Anwendung auch bei der Strukturaufklärung (Wishart and 
Case, 2001; Hunter, et al., 2005). Zudem hat sich die Beobachtung von Veränderungen 
der  CS  (CSP)  bezüglich  eines  Referenzzustands  zur  Untersuchung  biomolekularer 
Wechselwirkungen als sehr interessant herausgestellt. Die Messung von Veränderungen 
der  CS  sind  auch  Grundlage  eines  unter  dem  Namen  „SAR  by  NMR“  bekannt 
gewordenen fragmentbasierten Ansatzes zur Entwicklung von Liganden (Shuker, et al., 
1996).  Schwierigkeiten  bei  der  Interpretation  und  Modellierung  von  CSP  können 
umgangen werden,  indem  nur qualitative  Aussagen getroffen werden. Dieser Ansatz 
liefert aber keine Informationen über die Konfiguration des Protein-Ligand-Komplexes, 
die von einem Dockingverfahren zur Geometrievorhersage genutzt werden könnten. 
Ich habe im Rahmen dieser Arbeit einen neuen rechnerischen Ansatz entwickelt, der 
quantitative  CSP  von  Amidprotonen  auf  der  Proteinseite  zur  Verbesserung  eines 
Protein-Ligand-Dockingverfahrens  benutzt. Die  Methode nennt sich QCSPScore. Sie 
wurde in das AutoDock Softwarepaket implementiert, was eine komfortable Nutzung 
erlaubt. 
QCSPScore  wurde  als  eine  Hybridbewertungsfunktion  entwickelt,  die  DrugScore-
Potentiale (Gohlke, et al., 2000) mit einem Maß für die Übereinstimmung zwischen 
experimentell  gemessenen  und  vorhergesagten  quantitativen  CSP  für  eine  Docking-
Pose  linear  kombiniert.  Die  Vorhersage  der  CSP  erfolgt  dabei  mit  Hilfe  eines 
empirischen Modells, um die Effizienz des Ansatzes zu gewährleisten. Die vorliegende 
Arbeit  konzentriert  sich  auf  die  Behandlung  zweier  Fragen.  Erstens,  wie  die Zusammenfassung    99 
     
Übereinstimung  zwischen  experimentell  gemessenen  und  vorhergesagten  QCSP 
erfolgen kann, und, zweitens, wie der QCSP-Beitrag gegenüber DrugScore-Potentialen 
gewichtet werden muss. 
Da  für  die  Entwicklung  und  Testung  der  Methode  keine  großen  Datenmengen  zur 
Verfügung  standen,  habe  ich  eine  zweischrittige  Strategie  verfolgt.  In  einem  ersten 
Schritt habe ich mit 70 Protein-Ligand-Komplexen aus dem „Astex diverse“ Datensatz 
gearbeitet, für die ich CSP vorhergesagt habe. In einem zweiten Schritt habe ich die 
Ergebnisse  der  Untersuchung  dreier  Protein-Ligand-Komplexe  ausgewertet,  für  die 
experimentelle Daten vorlagen. 
Während  der  Entwicklung  der  Methode  wurden  die  untersuchten  Protein-Ligand-
Komplexe  auch  mit  herkömmlichen  DrugScore-Potentialen  bewertet.  Dies  führte  in 
71%  der  Fälle  zu  korrekt  vorhergesagten  Geometrien  (Abschnitt  5.2).  Diese  nativ-
ähnlich  vorhergesagten  Komplexe  habe  ich  anschließend  zusammen  mit  den  falsch 
vorhergesagten Komplexen zur Ableitung der funktionellen Form des QCSP-Beitrags 
zur Bewertungsfunktion benutzt. Dabei stellte sich der Rangkorrelationskoeffizient nach 
Kendall  als  nützlich  heraus  (Abschnitt  5.3).  Durch  die  Verwendung  dieses 
Korrelationskoeffizienten muss die Sättigung der Signale auf Proteinseite nicht mehr 
berücksichtigt  werden,  die  bei  verschiedenen  Protein-Ligand-Komplexen 
unterschiedlich  sein  und  die  Werte  der  CSP  beeinflussen  kann.  Außerdem  ist  der 
Rangkorrelationskoeffizient ein robustes Maß, verglichen mit Bewertungschemata, die 
auf  der  Minimierung  quadratischer  Differenzen  zwischen  experimentellen  und 
berechneten CSP beruhen. Meine Untersuchungen haben ergeben, dass die Sensitivität 
dieser  Bewertungsfunktionen  gegenüber  Ausreißern  in  vorhergesagten  Daten  ein 
Problem darstellt. 
Um die Gewichtung des QCSP-Beitrags in der linearen Kombination mit DrugScore-
Potentialen zu bestimmen, habe ich die „Energielücke“ (energy gap) zwischen den mit 
herkömmlichen DrugScore-Potentialen nativ-ähnlich bzw. nicht korrekt vorhergesagten 
Komplexen  untersucht  (Abschnitt  5.4).  Für  den  untersuchten  Datensatz  war  die 
maximale  Energielücke  für  DrugScore  mit  1,31  DrugScore-Einheiten  recht  niedrig. 
Werte  für  den  Rangkorrelationskoeffizienten  nach  Kendall  lagen  dagegen  zwischen 
0,29  für  die  nicht-korrekt  vorhergesagten  Komplexe  und  0,82  für  die  native-änlich 
vorhergesagten Komplexe, was auf einen Gewichtungsfaktor zwischen drei und zehn Zusammenfassung    100 
     
hindeutete  (Abschnitt  5.5).  Die  Tatsache,  dass  für  diese  idealen  Fälle  keine 
Ungenauigkeiten  durch  die  Vorhersage  von  CSP  auftreten  und  alle  Amidprotonen 
zugewiesen werden können, erlaubt die alleinige Beobachtung des Einflusses der CSP 
auf  das  Dockingergebnis.  Mit  dem  niedrigsten  getesteten  Gewichtungsfaktor 
(QCSP = 3) wurde eine Erfolgsrate beim Docking von 87% erzielt. Das bedeutet eine 
Verbesserung um 16% im Vergleich zum DrugScore-Ergebnis. Die Erfolgsrate konnte 
sogar  auf  100%  gesteigert  werden,  wenn  der  größte  getestete  Gewichtungsfaktor 
verwendet wurde (QCSP = 10). Hinzu kommt, dass die mit QCSPScore vorhergesagten 
Geometrien der nativen Komplexstruktur ähnlicher waren als die mit herkömmlichen 
DrugScore-Potentialen vorhergesagten. Dies wird deutlich, wenn ein RMSD  1,0 Å als 
ein strengeres Kriterium zum Beurteilen der Posen herangezogen wird. In diesem Fall 
wurden  47%  der  Komplexstrukturen  mit  herkömmlichen  DrugScore  korrekt 
vorhergesagt, aber 86% mit QCSPScore und dem Gewichtungsfaktor zehn (Abschnitt 
5.6).  In  der  Schlussfolgerung  hat  dieser  Teil  der  Arbeit  gezeigt,  dass  die  globale 
Optimierung auf der kombinierten EDS/EQCSP-Hyperfläche erfolgreich ist, was bei der 
Suche nach nativ-ähnlichen Lösungen zu besseren Ergebnissen führt. 
Die  Anwendung der  hybriden Bewertungsfunktion  mit dem Gewichtungsfaktor zehn 
auf die drei Systeme, für die experimentell bestimmte Daten vorliegen, ist erfolgreich, 
wenn  solche  Amidprotonen  unberücksichtigt  bleiben,  die  bei  der  Ausbildung  von 
Wasserstoffbrücken  beteiligt  sind  (Abschnitt  5.7).  Die  Verbesserung  gegenüber  der 
Verwendung herkömmlicher DrugScore-Potentiale ist signifikant, da letzteres in allen 
drei Fällen nicht erfolgreich ist. Außerdem werden nur bei Anwendung der hybriden 
Bewertungsfunktion nativ-ähnliche Komplexstrukturen für 1a9u und 1ydr vorhergesagt. 
Das  betont  wiederum  die  Wichtigkeit,  experimentelle  Daten  in  das  Docking  mit 
einzubeziehen,  und  zwar  nicht  nur  als  ein  Vor-  oder  Nachfilter,  wie  es  in  der 
Vergangenheit bereits praktiziert wurde. 
Der  Vergleich  der  QCSPScore-Vorhersagen  mit  experimentell  bestimmten  Daten 
ermöglichte die Erkennung von Einschränkungen des Ansatzes und Überlegungen, wie 
diese  Einschränkungen  überwunden  werden  können.  So  führte  beispielsweise  die 
Nichtberücksichtigung  von  CSP  von  Amidprotonen,  die  an  der  Ausbildung  von 
Wassersoffbrücken beteiligt sind, zu einer Verbesserung der Dockingergebnisse. Das 
war  zu  erwarten,  da  die  Methode  zur  Vorhersage  von  CSP  diesen  Effekt  nicht Zusammenfassung    101 
     
modellieren  kann.  Interessanter  war  die  Beobachtung,  dass  auch  die 
Nichtberücksichtigung elektrostatischer Effekte notwendig für gute Ergebnisse war. Da 
CSP  von  Amidprotonen  im  Experiment  breit  und  nicht  symmetrisch  verteilt  sind, 
können  nur  schwer  eindeutige  Muster  beobachtet  werden,  welche  die  Position  des 
Liganden markieren. Die alleinige Berücksichtigung von Ringstromeffekten führt dabei 
zu  besseren  Ergebnissen:  Ringstromeffekte  (sofern  vorhanden)  liefern  den  größten 
signifikanten Beitrag zu den gesamten beobachteten CSP. Außerdem erzeugen sie ein 
charakteristisches Muster von Veränderungen der CS in ihrer Umgebung und können 
somit  effektiv  zur  genauen  Positionierung  eines  Liganden  in  der  Bindetasche  des 
Proteins genutzt werden. Bei der Untersuchung weiterer Faktoren, die das Ergebnis des 
Dockings beeinflussen könnten, stellten sich Bindetaschenbewegungen von bis zu 2 Å 
RMSD als den Erfolg des Dockings nicht negativ beeinflussend heraus. Wenn die CSP 
gleichmäßig  verteilt  sind,  kann  zudem  eine  Zuweisung  von  nur  40%  oder  weniger 
toleriert werden. 
Die geringe Menge verfügbarer experimentell bestimmter Daten erlaubt es trotz dieser 
Erfolge  nicht,  alle  Vorteile  der  Methode  endgültig  herauszustellen.  Einige 
Einschränkungen  des  Verfahrens  konnten  aber  festgestellt  werden,  sowohl  was  die 
Theorie hinter der Methode, aber auch die experimentell bestimmten Daten betrifft. Um 
die Anwendungsmöglichkeiten der Methode zu verfeinern und zu erweitern, müssen 
diese Einschränkungen in zukünftigen Entwicklungen reduziert werden. 
Eine geringe Genauigkeit bei der Vorhersage von CSP von Amidprotonen zeigt dabei 
nur  einen  beschränkten  Einfluss  auf  den  Erfolg  des  Verfahrens  verglichen  mit 
unvollständigen  und  unregelmäßigen  Zuweisungsmustern.  Hinsichtlich  der 
Wasserstoffbrücken  wären  ein  besseres  Verständnis  und  eine  bessere  Behandlung 
elektrostatischer  Effekte  wünschenswert.  Gleiches  gilt  für  eine  Erweiterung  des 
Ansatzes unter Berücksichtigung von Proteinflexibilität. Hinsichtlich des Problems der 
Wasserstoffbrücken haben Moon und Case (Moon and Case, 2007) erst kürzlich ein 
erweitertes  empirisches  Modell  vorgestellt.  Es  bleibt  aber  nachzuprüfen,  ob  die 
Verwendung einer solchen Methode die Effizienz des Verfahrens nicht beeinträchtigt. 
Generalisierte  Born-Modelle  sind  eine  Alternative  zu  expliziten 
Lösungsmittelmodellen.  Es  ist  offen,  ob  solche  Modelle  effizient  in  QCSPScore 
implementiert werden können und ob der Gewinn an Genauigkeit tatsächlich die Kosten Zusammenfassung    102 
     
ausgleicht,  die  ein  solches  Verfahren  verursacht.  Effizientere  Methoden  zur 
Vorhersagen  von  CSP  auf  der  Ligandenseite  sind  vor  kurzem  ebenfalls  vorgestellt 
worden. NMRScore (Wang, et al., 2007) benutzt dafür quantenmechanische Ansätze. 
Dies ist nützlich zur Verfeinerung der Struktur, aber nicht für den Einsatz in Docking-
Verfahren mit mittlerem Durchsatz. 
Die  Konzentration  auf  Ringstromeffekte  schränkt  die  Fälle  an  Liganden  ein,  die 
untersucht werden können. Dies gilt aber  nur diejenigen 5% der Strukturen aus der 
„MDL  Drug  Data  Report“  Datenbank,  die  keine  aromatischen  Systeme  tragen.  Die 
Nichtberücksichtigung der Proteinflexibilität schränkt das Verfahren ebenfalls ein, ist 
aber weniger eine Beschränkung des QCSPScore als des zugrunde liegenden Docking-
Verfahrens. 
Ich  bin davon überzeugt, dass Verfahren wie QCSPScore für  mit Dockingverfahren 
schwierig  vorherzusagende  Protein-Ligand-Komplexe  deutliche  Verbesserungen 
bringen  können.  Dies  gilt  beispielsweise  im  Fall  des  fragmentbasierten 
Ligandenentwurfs (Congreve, et al., 2008), weil kleine Fragmente eine Herausforderung 
für  klassische  Bewertungsfunktionen  darstellen  (Hubbard,  et  al.,  2007;  Chen  and 
Shoichet,  2009),  und  für  Protein-Protein-Wechselwirkungsflächen  (Arkin  and  Wells, 
2004), die typischerweise relativ flache Bindestellen haben, die für gängige Docking-
Programme schwer anzugreifen sind (Gonzalez-Ruiz and Gohlke, 2006). Bibliography    103 
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Appendix: Implementation of QCSPScore 
All dockings were done using AutoDock 3.0.5, with DrugScore fields as base scoring 
function.  In  order  to  incorporate  the  EQCSP  term  and  construct  the  hybrid  scoring 
function we have extended AutoDock’s original code. The most salient features of the 
extended implementation are specified in the UML diagram in Figure A.1. The core of 
the modification consists of two new classes: AtomP and Protein_csp. The existing 
class  Eval  (used  by  AutoDock  for  evaluations  of  the  scoring  function)  has  been 
extended to contain  Protein_csp. A  Protein_csp object is  made of a number of 
AtomP  objects.  It  has  methods  for  reading  both  PDB  structural  data  and  the 
experimental CSP. Finally and for convenience, it also holds specific information about 
the  ligand:  which  atoms  are  involved  in  aromatic  rings  and  in  groups  generating 
anisotropy.  AtomP  objects  hold  the  individual  protons  for  which  CSP  have  to  be 
predicted (those for which experimental information is provided). 
 
Figure A.1 UML diagram of the most relevant modifications done to AutoDock 3, in 
order to incorporate the information about CSP to the scoring function (diagram 
generated with BOUML (http://bouml.free.fr)). Appendix: Implementation of QCSPScore    118 
     
Experimental CSPs, PDB with protein coordinates and ligand chemical groups relevant 
for the calculation of the CSP are passed to the program through a new line in the 
AutoDock’s input file. The weight for the EQCSP contribution is also specified at this 
point. A new DPF keyword (“shifts”) has been defined to request AutoDock to setup 
a calculation involving CSP. The example of the new input line: 
 
Figure A.2 Example of the new input line required to use AutoDock with our extension 
incorporating CSP. 
CSP are specified as in the example below (example line in the “file with CSP”): 
9 TYR  H   -0.010 
where the first column corresponds to residue number, the second to residue name, the 
third to the atom name, and the fourth to the experimental CSP. Chemical information 
of the ligand is specified as: 
ring 0.85 6 28 29 30 32 34 35 
where “ring” is a keyword that identifies an aromatic ring. Groups that are sources of 
anisotropic effects are  labelled  “cgroup”.  What  follows  is the  intensity of the ring 
factor (or the anisotropy), the number of atoms, and the atom numbers as in the pdbq 
file specified at the “move” keyword in a standard AutoDock run. 
At docking time for every conformation with favourable interacting energy (EDS < 0) the 
program  calls  the  get_CSP_Score()  procedure  from  Eval  class,  passing  to  it  the 
coordinates of the new trial ligand pose to compute EQCSP. EQCSP is only contributing to 
the  objective  function  during  docking  and  is  not  used  in  the  final  re-ranking  of 
solutions, if more than one docking is performed. For that final scoring and re-ranking, 
only DrugScore and the  internal  energy of the  ligand as computed by AutoDock is Appendix: Implementation of QCSPScore    119 
     
considered. All implementations have been done in C++ and a flag CSPDOCK has been 
defined for conditional compilation of the program (with or without CSP). Curriculum vitae    120 
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